<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Mol Divers</journal-id><journal-id journal-id-type="iso-abbrev">Mol Divers</journal-id><journal-title-group><journal-title>Molecular Diversity</journal-title></journal-title-group><issn pub-type="ppub">1381-1991</issn><issn pub-type="epub">1573-501X</issn><publisher><publisher-name>Springer International Publishing</publisher-name><publisher-loc>Cham</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">38739227</article-id><article-id pub-id-type="pmc">PMC11785706</article-id>
<article-id pub-id-type="publisher-id">10850</article-id><article-id pub-id-type="doi">10.1007/s11030-024-10850-8</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Different receptor models show differences in ligand binding strength and location: a computational drug screening for the tick-borne encephalitis virus</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Finke</surname><given-names>Felicitas</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Hungerland</surname><given-names>Jonathan</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Solov&#x02019;yov</surname><given-names>Ilia A.</given-names></name><address><email>ilia.solovyov@uni-oldenburg.de</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Schuhmann</surname><given-names>Fabian</given-names></name><address><email>fabian.schuhmann@nbi.ku.dk</email></address><xref ref-type="aff" rid="Aff4">4</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/033n9gh91</institution-id><institution-id institution-id-type="GRID">grid.5560.6</institution-id><institution-id institution-id-type="ISNI">0000 0001 1009 3608</institution-id><institution>Institute of Physics, </institution><institution>Carl von Ossietzky Universit&#x000e4;t, </institution></institution-wrap>Carl-von-Ossietzky-Str. 9-11, 26129 Oldenburg, Germany </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/033n9gh91</institution-id><institution-id institution-id-type="GRID">grid.5560.6</institution-id><institution-id institution-id-type="ISNI">0000 0001 1009 3608</institution-id><institution>Research Centre for Neurosensory Science, </institution><institution>Carl von Ossietzky Universit&#x000e4;t, </institution></institution-wrap>Carl-von-Ossietzky-Str. 9-11, 26129 Oldenburg, Germany </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/033n9gh91</institution-id><institution-id institution-id-type="GRID">grid.5560.6</institution-id><institution-id institution-id-type="ISNI">0000 0001 1009 3608</institution-id><institution>Center for Nanoscale Dynamics (CENAD), </institution><institution>Carl von Ossietzky Universit&#x000e4;t, </institution></institution-wrap>Ammerl&#x000e4;nder Heerstr. 114-118, 26129 Oldenburg, Germany </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/035b05819</institution-id><institution-id institution-id-type="GRID">grid.5254.6</institution-id><institution-id institution-id-type="ISNI">0000 0001 0674 042X</institution-id><institution>Niels Bohr International Academy, Niels Bohr Institute, </institution><institution>University of Copenhagen, </institution></institution-wrap>Blegdamsvej 17, 2100 Copenhagen, Denmark </aff></contrib-group><pub-date pub-type="epub"><day>13</day><month>5</month><year>2024</year></pub-date><pub-date pub-type="pmc-release"><day>13</day><month>5</month><year>2024</year></pub-date><pub-date pub-type="ppub"><year>2025</year></pub-date><volume>29</volume><issue>1</issue><fpage>281</fpage><lpage>292</lpage><history><date date-type="received"><day>9</day><month>2</month><year>2024</year></date><date date-type="accepted"><day>16</day><month>3</month><year>2024</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2024</copyright-statement><copyright-year>2024</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract id="Abs1"><p id="Par1">The tick-borne encephalitis virus (TBE) is a neurotrophic disease that has spread more rapidly throughout Europe and Asia in the past few years. At the same time, no cure or specific therapy is known to battle the illness apart from vaccination. To find a pharmacologically relevant drug, a computer-aided drug screening was initiated. Such a procedure probes a possible binding of a drug to the RNA Polymerase of TBE. The crystal structure of the receptor, however, includes missing and partially modeled regions, which rendered the structure incomplete and of questionable use for a thorough drug screening procedure. The quality of the receptor model was addressed by studying three putative structures created. We show that the choice of receptor models greatly influences the binding affinity of potential drug molecules and that the binding location could also be significantly impacted. We demonstrate that some drug candidates are unsuitable for one model but show decent results for another. Without any prejudice on the three employed receptor models, the study reveals the imperative need to investigate the receptor structure before drug binding is probed whether experimentally or computationally.</p><sec><title>Supplementary Information</title><p>The online version contains supplementary material available at 10.1007/s11030-024-10850-8.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Molecular dynamics</kwd><kwd>Drug discovery</kwd><kwd>Receptor models</kwd><kwd>AlphaFold</kwd></kwd-group><funding-group><award-group><funding-source><institution>Deutsche Forschungsgemeinschaft</institution></funding-source><award-id>SFB1372</award-id><award-id>GRK1885</award-id><award-id>GRK1885</award-id><principal-award-recipient><name><surname>Hungerland</surname><given-names>Jonathan</given-names></name><name><surname>Solov&#x02019;yov</surname><given-names>Ilia A.</given-names></name><name><surname>Schuhmann</surname><given-names>Fabian</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution>Volkswagen Foundation</institution></funding-source><award-id>Lichtenberg Professorship</award-id><principal-award-recipient><name><surname>Solov&#x02019;yov</surname><given-names>Ilia A.</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution>Nieders&#x000e4;chsisches Ministerium f&#x000fc;r Wissenschaft und Kultur</institution></funding-source><award-id>SMART</award-id><award-id>SMART</award-id><principal-award-recipient><name><surname>Solov&#x02019;yov</surname><given-names>Ilia A.</given-names></name><name><surname>Schuhmann</surname><given-names>Fabian</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution>Novo Nordisk Fonden</institution></funding-source><award-id>NNF22OC0079182</award-id><principal-award-recipient><name><surname>Schuhmann</surname><given-names>Fabian</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution>Carl von Ossietzky Universit&#x000e4;t Oldenburg (3092)</institution></funding-source></award-group><open-access><p>Open Access funding enabled and organized by Projekt DEAL.</p></open-access></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; Springer Nature Switzerland AG 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par2">The tick-borne encephalitis (TBE) virus is a neurotropical disease with flu-like symptoms that may evolve to a severe neurological illness. The virus can be subdivided into three main types, namely the European TBE (TBE-Eu), the Siberian TBE (TBE-Sib), and the far eastern variant (TBE-FE) [<xref ref-type="bibr" rid="CR1">1</xref>], that differ by their death toll. Primarily, TBE-FE is associated with a severe course of the illness with long-lasting neurological effects [<xref ref-type="bibr" rid="CR2">2</xref>] and a death toll of 20&#x02013;60% of the infected. The other variants of the virus, TBE-Eu and TBE-Sib, exhibit a death rate of 1&#x02013;2% and 6&#x02013;8%, respectively [<xref ref-type="bibr" rid="CR3">3</xref>]. However, the virus subtype alone is not the only criterion for a mild or severe case of the disease, as for each subtype any scenario is possible, and the implications are mainly influenced by the age or genetic predisposition of the patient [<xref ref-type="bibr" rid="CR1">1</xref>].</p><p id="Par3">The different TBE virus subclasses can be found in Europe and Asia and are classified as an epidemic in numerous countries. [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>]. The disease associated with the TBE virus is notifiable in the European Union since 2012 [<xref ref-type="bibr" rid="CR1">1</xref>]. According to the Annual Epidemiological Report of the ECDC (European Centre for Disease Prevention and Control), 24 countries within the European Economic Area reported a total of 3,734 cases of TBE in 2020 and an increase in the more recent years [<xref ref-type="bibr" rid="CR2">2</xref>]. For instance, the reported cases increased by 30% in Germany in 2023 compared to 2022 [<xref ref-type="bibr" rid="CR6">6</xref>].</p><p id="Par4">The disease is mainly transmitted through tick bites [<xref ref-type="bibr" rid="CR7">7</xref>]. In 1% of the cases, it is transmitted through consumption of products stemming from infected animals, like unpasteurized milk from cows, sheep, or goats. A case of a direct infection transmitted from human to human is not known [<xref ref-type="bibr" rid="CR8">8</xref>]; however, a case has been reported in which the virus was transmitted through the transplantation of infected organs [<xref ref-type="bibr" rid="CR9">9</xref>].</p><p id="Par5">Even though the TBE virus is widely spread in Europe and Asia and studies have been performed to inhibit the similar Japanese encephalitis virus or the Zika virus [<xref ref-type="bibr" rid="CR10">10</xref>&#x02013;<xref ref-type="bibr" rid="CR13">13</xref>], no medication is known to treat it, which reduces the options for supporting or symptomatic treatments, while effective vaccinations are available [<xref ref-type="bibr" rid="CR1">1</xref>].</p><p id="Par6">With rising global temperatures, the odds of ticks surviving winter increases, thereby boosting the chances of infection. The rising numbers highlight the need for specific medications that can be employed post-infection. Fortunately, nowadays suggestions for potentially pharmaceutically relevant drug candidates can be established computationally to screen a large number of potential drugs and find well-binding candidates prior to the individual experimental tests [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR15">15</xref>]. The present investigation focuses on such a virtual drug screening procedure for the RNA-dependent polymerase (RdRp) protein of the TBE virus with the aim to find putative medicinally relevant drug ligands. A collection of 2,000 ligand molecules were investigated, similar to the frequently studied drug molecule that has the potency to inhibit the RdRp protein, namely the 7-Deaza-2&#x02019;C-methyladenosine (7DMA); the 7DMA molecule has been documented to effect some viruses from the flavivirus genus [<xref ref-type="bibr" rid="CR7">7</xref>].</p><p id="Par7">The TBE virus contains an RdRp protein, which is essential for the replication of the virus inside the host system. The RdRp protein is highly conserved through various viruses of the flavivirus genus, which also includes the TBE virus. Such conservation might indicate the specific importance and sensitivity of the protein and thus reduces the chance that the virus can successfully undergo a sustainable mutation to gain immunity against the putative medications. Furthermore, it was shown in mice that the protein inhibits the growth of the neurites, which directly favors the onset of the neurological phase of the disease [<xref ref-type="bibr" rid="CR16">16</xref>]. Lastly, the protein does not have a eucaryotic homologous counterpart. Therefore, a successful drug might have little to no secondary effects on human cells [<xref ref-type="bibr" rid="CR7">7</xref>].</p><p id="Par8">The RdRp protein structure is only partially available in its crystalline form with 98 out of 638 (partially) missing residues. The present study attempts to reconstruct the missing parts of the RdRp receptor through computational modeling. Three structural models were established and their differences and similarities rationalized. The first model employs the homology modeling approach relying on the SWISS-MODEL platform [<xref ref-type="bibr" rid="CR17">17</xref>&#x02013;<xref ref-type="bibr" rid="CR21">21</xref>]. The second model employs AlphaFold [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR23">23</xref>] to reconstruct the structure of the entire receptor. The third model uses AlphaFold to replace only the partially modeled or missing residues, while keeping the rest of the crystal structure unchanged. The multiple models were considered to address the low-confidence regions in the receptor structure, such that the structure obtained using SWISS-MODEL could be compared to the two other models from the same virus genus. As computer-generated protein structures have warrying confidence levels in different regions, it is natural that no structure can be proven to be the only correct one.</p><p id="Par9">The 2,000 potential drug ligands were then tested for all three models individually using the Automated Ligand Searcher (ALISE) [<xref ref-type="bibr" rid="CR26">26</xref>], which is incorporated into the browser-based computational platform VIKING (Scandinavian online kit for nanoscale modeling) [<xref ref-type="bibr" rid="CR27">27</xref>].</p><p id="Par10">The most-promising ligands for all three models were compared in their binding energy and binding location. We have found that the atomistic details in the receptor structure severely influence the potential drug binding affinity and that it is unpractical to unquestioningly rely on a receptor structure obtained using any modeling tool. Three ligands were identified as the best-performing ligands in two of the three receptor models, making them the most robust independent of the receptor. While the results should be considered with care, an experimental study of these ligands might significantly further the cause in finding a medically relevant drug against the TBE virus.</p></sec><sec id="Sec2"><title>Background and methods</title><sec id="Sec3"><title>The receptor structure</title><p id="Par11">A potentially viable receptor for drug targeting and the inhibition of the TBE virus is its RNA-dependent RNA-polymerase (RdRp), which is essential for the self-replication of the virus. The RdRp protein is at the C-terminal of the so-called NS5 non-structural protein inside the virus, which consists of the methyltransferase domain followed by the polymerase domain [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR16">16</xref>].
</p><p id="Par12">Figure&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref> shows the major motifs in the structure of the RdRp protein of the TBE virus and its so-called right-hand architecture, which forms a catalytic unit. The structure is subdivided into three regions, surrounding the active site of the RdRp receptor. The thumb domain is shown in gray-blue, the finger domain in blue, and the palm domain in teal. The priming loop (red) is part of the thumb domain. Overall, the right-hand architecture can be further classified through the abundance of functional motifs, denoted as A&#x02013;G in Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>B. The motifs A, B, C, and F interact directly with the nucleoside triphosphate (NTP), which is the precursor for RNA synthesis.<fig id="Fig1"><label>Fig. 1</label><caption><p><bold>A</bold> Right-hand-architecture of the RdRp Protein of the TBE virus. The structure is subdivided into three regions surrounding the active site in its center. The so-called thumb domain is shown in gray-blue, the finger domain in blue, and the palm domain in teal colored. The priming loop (red) is part of the thumb domain. <bold>B</bold> Colored representation of the different motifs in the RdRp protein structure. Motifs A, B, C, and F interact directly with the so-called NTP. The other motifs are endowed with structural responsibilities</p></caption><graphic xlink:href="11030_2024_10850_Fig1_HTML" id="MO1"/></fig></p><p id="Par13">The potential drug binding site of the RdRp protein is located in its active center, where the RNA transcription takes place. The priming loop limits the accessibility to the active site, so only ssRNA may enter the center during the initialization of the transcription [<xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR29">29</xref>]. A well-binding drug ligand might, therefore, prohibit initialization of the RNA synthesis.</p><p id="Par14">A crystal structure for the RdRp protein with the PDB ID 7D6N [<xref ref-type="bibr" rid="CR28">28</xref>] is available in the PDB database [<xref ref-type="bibr" rid="CR30">30</xref>]. The protein sequence comprises 638 amino acid residues, of which, in total, 19 residues at the N- and C-terminal have not been reconstructed. Furthermore, the crystal structure does not contain the well-defined positions of 50 amino acid residues and exhibits unmodeled side chains for 48 amino acid residues (see Table <xref rid="MOESM1" ref-type="media">A1</xref> in the Supplementary Material (SM)). As the partially modeled or missing residues are expected to be close to the active center, modeling methods were employed to obtain a more complete receptor structure.</p><p id="Par15">Three different modeling methods were employed to generate the receptor structure. The first method uses the SWISS-MODEL [<xref ref-type="bibr" rid="CR31">31</xref>] homology modeling, and the second utilizes the artificial intelligence workflow provided by AlphaFold [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR23">23</xref>]. Lastly, a hybrid model was considered, where the structural information obtained from AlphaFold was merged with the crystal structure, effectively replacing the missing and partially modeled regions.</p><p id="Par16">The receptor obtained from SWISS-MODEL [<xref ref-type="bibr" rid="CR17">17</xref>&#x02013;<xref ref-type="bibr" rid="CR21">21</xref>] requires the RdRp protein&#x02019;s sequence and is denoted as Swiss. A visual inspection of the resulting receptor model showed some differences in crystal structures of similar viruses: the Japanese encephalitis virus (PDB ID 4K6M) [<xref ref-type="bibr" rid="CR10">10</xref>] or the Zika virus (PDB ID 5TFR) [<xref ref-type="bibr" rid="CR11">11</xref>], which belong to the same virus genus as the TBE virus. The Japanese encephalitis virus structure and the Zika virus exhibit less unmodeled residues and have been subjected to drug docking procedures in the past [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR13">13</xref>].</p><p id="Par17">A visual representation of the differences is shown in Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>. With this in mind, different receptor models were employed to compare the drug ligand binding results. No judgement is made, however, on the realism of any of the resulting receptor models.<fig id="Fig2"><label>Fig. 2</label><caption><p><bold>A</bold> The structure obtained from the Swiss model is colored according to the certainty estimated by the modeling process (arb. units). The certainty is measured on a scale from 0 to 100, with 0 describing an uncertain region and 100 denoting a high confidence. <bold>B</bold> The uncertain region obtained from the Swiss model is highlighted in red, while the same region is overlaid with the structure of the Japanese encephalitis virus (yellow) and the Zika virus (cyan)</p></caption><graphic xlink:href="11030_2024_10850_Fig2_HTML" id="MO2"/></fig></p><p id="Par18">The second receptor was generated using AlphaFold [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR23">23</xref>]. AlphaFold only requires the amino acid sequence to generate a three-dimensional protein structure, but the generated structure can be refined by selected homologous crystal structures. In this case, the algorithm used four crystal structures for refinement (pdb IDs: 4C11 [<xref ref-type="bibr" rid="CR24">24</xref>], 5U0C [<xref ref-type="bibr" rid="CR25">25</xref>], 4K6M [<xref ref-type="bibr" rid="CR10">10</xref>], 5U0B [<xref ref-type="bibr" rid="CR25">25</xref>]). AlphaFold is an artificial intelligence tool trained on the existing crystal structures, which are, for instance, located in the PDB database. AlphaFold also generates the N- and C- terminal residues, which were completely unmodeled in the crystal structure. To match all studied models, these 19 amino acid residues were subsequently removed. Alpha denotes the receptor model obtained from AlphaFold.</p><p id="Par19">Finally, because AlphaFold relies on the predictions from all available crystal structures, and not necessarily on the ones matching the RdRp protein of the TBE virus, a hybrid model was constructed, denoted by Hybrid. The model was obtained by aligning the crystal structure and Alpha model. The partially modeled or missing amino acid residues in the crystal structure were then inserted into the crystal structure from the Alpha model. The hybrid model, therefore, directly contains information from the crystal structure, supplemented by the information obtained with AlphaFold.</p><p id="Par20">In the last step, the protonation states of the different amino acid residues had to be taken into account as, for instance, a wrongly protonated histidine residue can have significant effects on the binding affinity of molecules [<xref ref-type="bibr" rid="CR32">32</xref>]. Considering a physiological pH-value of 7.4 [<xref ref-type="bibr" rid="CR33">33</xref>], the so-called <inline-formula id="IEq1"><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\text{p}K_a$$\end{document}</tex-math><mml:math id="M2"><mml:mrow><mml:mtext>p</mml:mtext><mml:msub><mml:mi>K</mml:mi><mml:mi>a</mml:mi></mml:msub></mml:mrow></mml:math><inline-graphic xlink:href="11030_2024_10850_Article_IEq1.gif"/></alternatives></inline-formula> values can be calculated, which was done employing the PROKKA3 program [<xref ref-type="bibr" rid="CR34">34</xref>, <xref ref-type="bibr" rid="CR35">35</xref>] for the Swiss model. The resulting <inline-formula id="IEq2"><alternatives><tex-math id="M3">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\text{p}K_a$$\end{document}</tex-math><mml:math id="M4"><mml:mrow><mml:mtext>p</mml:mtext><mml:msub><mml:mi>K</mml:mi><mml:mi>a</mml:mi></mml:msub></mml:mrow></mml:math><inline-graphic xlink:href="11030_2024_10850_Article_IEq2.gif"/></alternatives></inline-formula> values, see Table <xref rid="MOESM1" ref-type="media">B1</xref> in the Supplementary Materials, combined with a visual inspection, led to changes in the protonation of histidines. By default, all histidines were considered to be <inline-formula id="IEq3"><alternatives><tex-math id="M5">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\delta $$\end{document}</tex-math><mml:math id="M6"><mml:mi>&#x003b4;</mml:mi></mml:math><inline-graphic xlink:href="11030_2024_10850_Article_IEq3.gif"/></alternatives></inline-formula>-protonated, with only the His180 being <inline-formula id="IEq4"><alternatives><tex-math id="M7">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\varepsilon $$\end{document}</tex-math><mml:math id="M8"><mml:mi>&#x003b5;</mml:mi></mml:math><inline-graphic xlink:href="11030_2024_10850_Article_IEq4.gif"/></alternatives></inline-formula>-protonated. Furthermore, the Asp402 residue was additionally protonated. To keep the comparability of receptor models consistent, the protonation states from the Swiss model were also used for the Alpha and Hybrid models.</p><p id="Par21">After the structures were modeled and the protonation states were set, a molecular dynamics (MD) simulation was conducted in multiple steps to equilibrate the structures. For the MD simulation, the VIKING platform was employed [<xref ref-type="bibr" rid="CR27">27</xref>], which relies on the simulation software NAMD [<xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR37">37</xref>] and VMD [<xref ref-type="bibr" rid="CR38">38</xref>] for file preparation. All equilibration stages employed the CHARMM force field with CMAP corrections [<xref ref-type="bibr" rid="CR39">39</xref>&#x02013;<xref ref-type="bibr" rid="CR41">41</xref>] with a temperature of 310 K. The systems were neutralized, and sodium chloride ions were added to achieve a salt concentration of 0.15 mol/L. In the first two stages, the MD simulation was conducted in an NPT (constant number of atoms, pressure, and temperature) ensemble with a timestep of 1 fs and a pressure of 1.01325 bar. Everything but the solvent was restrained in the first stage, while in the second stage, the amino acid residue&#x02019;s side chains were allowed to move. The first stage was initiated with 1000 conjugate gradient minimization steps. Stages three and four were conducted in the NVT (constant number of atoms, volume, and temperature) ensemble. In the third stage, no restraints on atomic positions were imposed. Finally, in stage 4, the integrator time step was set to 2 fs, and the covalent bond to hydrogen atoms were considered rigid. The receptor protein structures were simulated for 30 ns in stage 4. For the Hybrid equilibration, a second minimization step was introduced to account for the artificially over-long bonds generated through the manual combination of Alpha and the crystal structures.</p><p id="Par22">The final snapshots from the equilibration simulation were further used for the drug screening workflow.</p></sec><sec id="Sec4"><title>Automated ligand searcher</title><p id="Par23">All three receptor models of the RdRp protein were used in the ALISE program [<xref ref-type="bibr" rid="CR26">26</xref>] to predict possible drug-like ligands that could bind inside the receptor. ALISE is an automated workflow incorporated into the VIKING online platform [<xref ref-type="bibr" rid="CR27">27</xref>], which sorts ligands based on their binding affinity to a provided receptor model. A search space to limit the docking to physiologically sensible binding sites can also be defined which was chosen to be the active center in the middle of the receptor structures. Different ligand molecules were generated by ALISE that was provided with the SMILES string of 7DMA, a known drug for viruses similar to the TBE virus. The search space for the drug docking was chosen to contain the RNA and the NTP binding location to block the most important functions of the receptor. With this information, ALISE automatically found 2000 similar ligands according to the Tanimoto score in the PubChem database [<xref ref-type="bibr" rid="CR26">26</xref>]. The Tanimoto score <italic>K</italic> is given for two molecular fingerprints by [<xref ref-type="bibr" rid="CR42">42</xref>]<disp-formula id="Equ1"><label>1</label><alternatives><tex-math id="M9">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\begin{aligned} K=\frac{|A\cap B|}{|A\cup B|}. \end{aligned}$$\end{document}</tex-math><mml:math id="M10" display="block"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:mi>K</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mo stretchy="false">|</mml:mo><mml:mi>A</mml:mi><mml:mo>&#x02229;</mml:mo><mml:mi>B</mml:mi><mml:mo stretchy="false">|</mml:mo></mml:mrow><mml:mrow><mml:mo stretchy="false">|</mml:mo><mml:mi>A</mml:mi><mml:mo>&#x0222a;</mml:mo><mml:mi>B</mml:mi><mml:mo stretchy="false">|</mml:mo></mml:mrow></mml:mfrac><mml:mo>.</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math><graphic xlink:href="11030_2024_10850_Article_Equ1.gif" position="anchor"/></alternatives></disp-formula>ALISE relies on a three-step process in which, gradually, potential ligands are filtered out, while the computational accuracy of the binding prediction increases. Drug docking is performed in the first step relying on the docking program Vina (AutoDock Vina 1.1.2)[<xref ref-type="bibr" rid="CR43">43</xref>] , with ligands being prepared by the AutoDockTools [<xref ref-type="bibr" rid="CR44">44</xref>] and Openbabel [<xref ref-type="bibr" rid="CR45">45</xref>] programs. The docked ligands were then sorted according to their binding scores. The highest-ranked 30 ligands of the docking phase were then considered in the second step of ALISE relying on atomistic MD simulations.</p><p id="Par24">The MD simulation phase includes simulations of the receptor, the ligand, and a complex consisting of the receptor and ligand in an implicit solvent [<xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR46">46</xref>]. While the docking procedure in the first step is static, the MD simulations allow motions in the receptor and ligand. These motions, for instance, might lead to a repulsion and force ligands to leave the binding pocket, which is a clear indication of a low binding affinity. The binding energy of the ligands was estimated from the three different simulations per ligand (receptor only, ligand only, and complex simulations), and the ligands were sorted by their binding affinity. ALISE employs the molecular mechanics-generalized Born and surface area continuum solvation (MM/GBSA) method [<xref ref-type="bibr" rid="CR46">46</xref>]. ALISE&#x02019;s MD step employs NAMD [<xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR37">37</xref>], while the simulation files were prepared using VMD [<xref ref-type="bibr" rid="CR38">38</xref>]. The Charmm General Force Field (cgenFF) [<xref ref-type="bibr" rid="CR47">47</xref>] was employed for the ligands, while the receptor was modeled using the Charmm Force Field with CMAP corrections [<xref ref-type="bibr" rid="CR40">40</xref>, <xref ref-type="bibr" rid="CR48">48</xref>&#x02013;<xref ref-type="bibr" rid="CR54">54</xref>].</p><p id="Par25">The five highest-scoring ligands from the MD step were subjected to a free energy perturbation (FEP) stage. In the FEP stage, windowed MD simulations were conducted in which the interactions between the receptor and the ligand were gradually decoupled and recoupled. Conformational restraints are used and later subtracted to avoid a diffusion of the ligand when the interactions are completely decoupled. Such an approach allows the most precise estimate for the binding free energy and establishes the final ranking of the remaining ligands [<xref ref-type="bibr" rid="CR26">26</xref>]. A total of 50 simulation windows were employed, each including an MD equilibration. The FEP step employs NAMD [<xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR37">37</xref>] with an explicit solvent and the same force fields and parameters as used in the MD step described above.</p></sec></sec><sec id="Sec5"><title>Results</title><sec id="Sec6"><title>Stability</title><p id="Par26">Following the initial equilibration MD simulations, the stabilities of the structures were validated by employing the Root Mean Square Deviation (RMSD) analysis. The RMSD values for the last snapshot of the equilibration simulations are compiled in Table <xref rid="Tab1" ref-type="table">1</xref> to compare the different structures with each other. The RMSD was additionally calculated for the regions with high and low certainties, following the structure prediction based on the Swiss model. A visual representation of the confidence is shown in Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>A. The resulting values suggest that the three receptor structures are relatively similar with each other in the high-certainty regions, while Swiss and Alpha models differ significantly in the uncertainty regions. Additionally, the RMSD time evolution for the entire protein is shown in Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>. The overall low RMSD below 4 &#x000c5; for the protein consisting of 619 residues indicates fairly stable structures [<xref ref-type="bibr" rid="CR55">55</xref>&#x02013;<xref ref-type="bibr" rid="CR59">59</xref>]. Additionally, even though the magnitude of the fluctuations is higher in the Hybrid and Swiss model compared to the Alpha model, they seem to evolve around a flat plateau after 10 ns or 20 ns, respectively.<table-wrap id="Tab1"><label>Table 1</label><caption><p>The root mean square deviation (RMSD) between the final configurations of the different receptor models</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Reference simulation</th><th align="left">Swiss compared to hybrid (&#x000c5;)</th><th align="left">Swiss compared to Alpha (&#x000c5;)</th><th align="left">Hybrid compared to Alpha (&#x000c5;)</th></tr></thead><tbody><tr><td align="left">Whole protein</td><td align="left">3.93</td><td align="left">4.24</td><td align="left">3.66</td></tr><tr><td align="left">Low certainty</td><td align="left">12.19</td><td align="left">12.78</td><td align="left">4.81</td></tr><tr><td align="left">High certainty</td><td align="left">3.04</td><td align="left">3.35</td><td align="left">3.60</td></tr></tbody></table><table-wrap-foot><p>The RMSD is calculated for the whole protein, high-certainty, and low-certainty regions as estimated by the SWISS model platform [<xref ref-type="bibr" rid="CR17">17</xref>] during receptor generation. In this table, the high-certainty regions have a confidence score above 50; low certainty are the regions below 50 as seen in Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>A. All receptor models are similar in the high-certainty regions, while significant differences are found primarily between Swiss and Alpha models in the low-certainty regions</p></table-wrap-foot></table-wrap><fig id="Fig3"><label>Fig. 3</label><caption><p>The three panels show the time evolution of the RMSD for the whole protein during the 30 ns equilibration phase. For each panel, structures were aligned to the respective reference structures prior to RMSD calculation, i.e., in the first panel, all three simulation trajectories are aligned to the first snapshot of the Alpha model simulation. The dependencies show an overall stable behavior of the different receptor models with most fluctuations in the Hybrid model. Throughout the simulation, one also notices that the Swiss model differs more from the Alpha model than the Hybrid model and that the Hybrid model and the Alpha model are similarly dissimilar to the Swiss model, concurring with the expectations</p></caption><graphic xlink:href="11030_2024_10850_Fig3_HTML" id="MO3"/></fig></p></sec><sec id="Sec7"><title>Drug screening</title><p id="Par28">Following the stability analysis of the different receptor models, the virtual screening program ALISE was used to study the binding affinity of a variety of ligands. The three steps of ALISE were conducted automatically, starting with the drug docking stage. All stages were completed for the three studied receptor models. After each step, ALISE ranks the ligands; the best-performing ligands are then advanced to the next stage:</p><p id="Par29">The ranking for the best 50 docked ligands in their five best binding positions is provided in Tables <xref rid="MOESM1" ref-type="media">C2</xref>&#x02013;<xref rid="MOESM1" ref-type="media">C4</xref> in the Supplementary Material. The 30 best-performing ligands were considered for the MD stage. During the MD stage, all atoms in the system are free to move and exhibit attraction and repulsion interactions. These interactions might result in the ligand to leave the originally determined binding pocket. Therefore, additionally to a more rigorous estimate of the binding energy, ligands that propelled out of their binding pocket can be excluded from further testing. The different locations of the potential ligands obtained from the docking stage provide different starting configurations for the MD simulations.</p><p id="Par30">The binding free energy estimated from the MD simulations for all receptors and all ligands is summarized in the Supplementary Material (see Tables <xref rid="MOESM1" ref-type="media">D5</xref>&#x02013;<xref rid="MOESM1" ref-type="media">D7</xref> in Supplementary Material). A visual inspection of the bound ligands in the different receptors reveals three noteworthy results.<fig id="Fig4"><label>Fig. 4</label><caption><p>Two ligands are shown within the Hybrid model receptor, with the priming loop in red. Ligand 1 (yellow) is the only ligand that obtained a negative binding energy in the MD stage, while the other 10 best-performing ligands, represented by the exemplary ligand 2 (blue), perform more poorly</p></caption><graphic xlink:href="11030_2024_10850_Fig4_HTML" id="MO4"/></fig></p><p id="Par31">In the course of completed MD simulations, most ligands were able to stay in their originally placed binding locations as determined by the docking stage. The original binding locations may differ, however, even within a single receptor model. Figure&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref> shows the positioning of the second-ranked ligand (yellow) compared to an exemplary ligand (blue), which represents the orientations of the majority of the 10 best-performing ligands bound in the Hybrid model. During the MD stage, it is revealed that only the yellow ligand results in a favorable binding energy. Thus, the ALISE&#x02019;s MD step corrects unphysical placements of ligands during the docking stage.</p><p id="Par32">Another example is provided by the ligand with the PubChem ID 189237 which was ranked among the best 30 performing ligands in the docking stage for all three receptors; however, its placement inside the receptors turned out to be different. The ligand was thus subjected to MD simulations three times, once for each receptor model. Figure&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref> shows the ligand&#x02019;s positioning in the different receptor models. The Swiss and Hybrid model are consistent with each other in respect to the ligand binding location, but not orientation. The Alpha model features the ligand on the opposite side of the priming loop.<fig id="Fig5"><label>Fig. 5</label><caption><p>Binding locations for the ligand with the PubChem ID 189237 within the different receptor models. In the Alpha model, the same ligand exhibits a different binding site on the other side of the priming loop compared to the Swiss and Hybrid Models</p></caption><graphic xlink:href="11030_2024_10850_Fig5_HTML" id="MO5"/></fig></p><p id="Par33">Another result followed from the visual inspection of conformations of the final snapshot of the different MD simulations. Here, the Trp533 residue in the Swiss and Alpha model receptor was studied, which turned out to assume two different distinct orientations as visualized in Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>. It turns out that the side chain orientation, as seen in the Alpha model, actively perturbs the potential drug binding location, as has been identified, for example, for the ligand with the PubChem ID 189237, seen in Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>B. Figure&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>A shows the orientation of the tryptophan in the Swiss model with the bound ligand. The slight change in side chain orientation might, therefore, significantly affect the binding site.<fig id="Fig6"><label>Fig. 6</label><caption><p>Orientation of the tryptophan 533 residue in the Swiss model (<bold>A</bold>) and the Alpha model (<bold>B</bold>). The panels also show the placement of the ligand with the PubChem ID 189237 in the Swiss model. The difference in orientation of the tryptophan side chain perturbs the potential binding site of the ligand, making it impossible to bind to that particular location. The slight change in side chain orientation might, therefore, significantly affect the ligand binding site</p></caption><graphic xlink:href="11030_2024_10850_Fig6_HTML" id="MO6"/></fig></p><p id="Par34">Five ligands with the best binding energy estimates from the MD simulations were subjected to the FEP calculations. Remarkably, not a single ligand had simultaneously a favorable (negative) binding free energy for all the three receptor models. However, three ligands still showed binding affinity for two receptor structures. The chemical structure of these three ligands is illustrated in Fig.&#x000a0;<xref rid="Fig7" ref-type="fig">7</xref>. The binding free energies estimated by the FEP stage are given in Table <xref rid="Tab2" ref-type="table">2</xref>. The ligands occurring in two receptor models are colored according to their pair. Complete tables containing individual contributions can be found in the Supplementary Material (see Tables <xref rid="MOESM1" ref-type="media">E8</xref>&#x02013;<xref rid="MOESM1" ref-type="media">E10</xref> in Supplementary Material). To validate the binding locations of the three reoccurring ligands, additional MD simulations were performed for the highlighted receptor-ligand complexes in three replicas each. Based on an RMSD analysis, the ligands maintain their location in the receptor structure for at least another 100 ns. A time evolution of the RMSD for the validation simulations is found in Fig.&#x000a0;F11.<fig id="Fig7"><label>Fig. 7</label><caption><p>Structural formulas for the three most robust ligands that show favorable binding across the different receptor models. The corresponding PubChem IDs are indicated. The ligands in <bold>B</bold> and <bold>C</bold> are structurally identical; however, the ligand in (<bold>B</bold>) is an enantiomer of the ligand in (<bold>C</bold>)</p></caption><graphic xlink:href="11030_2024_10850_Fig7_HTML" id="MO7"/></fig></p></sec><sec id="Sec8"><title>Comparison of high-ranking ligands</title><p id="Par36">Differences in the starting configuration for the FEP calculations carry over from the MD simulations. As such, the binding location may differ within the three ligands. For instance, the ligand with the PubChem ID 10302205 (rank four in the Swiss model, rank two in the Hybrid model) exhibits a slightly different orientation in the Swiss and Hybrid models, respectively; a visual inspection shows that the ligand might prohibit the ssRNA from entering the structure of the receptor in the Swiss model. At the same time, the ligand&#x02019;s location might indicate an inhibition of the NTP interaction in the Hybrid model. As NTP is a precursor to synthesizing RNA, blocking its interaction site makes the ligand a likely inhibitor for the virus. More precisely, in the Swiss model, the ligand is exposed to a large surface area of the motifs B and F and parts of the motifs C and E of the receptor, see Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>B. In the Hybrid model, the ligand is close to the A, B, C, and F motifs. Figure&#x000a0;<xref rid="Fig8" ref-type="fig">8</xref> shows a visualization of the drug binding location and orientation at the beginning of the FEP calculations. The A, B, C, and F motifs interact directly with the NTP. Therefore, one can suspect that the ligand may block the binding site for the NTP and significantly influence the functionality of the RdRp. Furthermore, the ligand binds fairly robustly with a binding free energy of negative 13&#x02013;16 kcal/mol to both receptor models (see Table <xref rid="Tab2" ref-type="table">2</xref>).<fig id="Fig8"><label>Fig. 8</label><caption><p>Positioning of the ligand with the PubChem ID 10302205 inside the Swiss model (<bold>A</bold>) and the Hybrid model (<bold>B</bold>). In the Swiss model, the ligand is located in the center of the active site, potentially interacting with the B, C, E, and F motifs. In the Hybrid model, the ligand is close to the A, B, C, and F motifs</p></caption><graphic xlink:href="11030_2024_10850_Fig8_HTML" id="MO8"/></fig><table-wrap id="Tab2"><label>Table 2</label><caption><p>The binding free energies obtained from the FEP stage in the ALISE workflow are shown for the different receptor models</p></caption><graphic position="anchor" xlink:href="11030_2024_10850_Tab2_HTML" id="MO16"/><table-wrap-foot><p>The ligands are indicated by their PubChem ID. The highlighted ligands ranked among the best-performing five ligands in the MD stage for two different receptor models. A detailed account of binding free energy estimates is given in the Supplementary Material (Tables <xref rid="MOESM1" ref-type="media">E8</xref>&#x02013;<xref rid="MOESM1" ref-type="media">E10</xref> in Supplementary Material)</p></table-wrap-foot></table-wrap></p><p id="Par37">The ligand with the Pubchem ID 132074004 is ranked first in the Hybrid model and fourth in the Alpha model. The ligand has a similar position in both receptor models, but a different orientation. While the triphosphate region is oriented in different directions, the ligand&#x02019;s aromatic rings share a similar location. The ligand is close to the A, B, C, and F motifs, similar to the binding site exhibited in Fig.&#x000a0;<xref rid="Fig8" ref-type="fig">8</xref>B. Hence, the ligand might also inhibit NTP interactions.</p><p id="Par38">Lastly, the ligand with the PubChem ID 21910880, which ranks highest in the Swiss model, was the least performing ligand in the Hybrid model with a binding free energy estimate of &#x02212;&#x000a0;0.39&#x000a0;kcal/mol. The binding energy value close to zero indicates a weak binding and small perturbations might already lead to the drug molecule&#x02019;s detachment. Additionally, the ligand is located in the poor confidence region of the receptor with the greatest structural variability. The ligand is, however, an enantiomer on the base of the previous ligand with the Pubchem ID 132074004; in other words, they are configurationally isomeric.</p><p id="Par39">Considering that the ligands 132074004 and 21910880 are structurally similar, the racemat (21910880) is within the best five performing ligands for all three receptor models, which makes it the most robust ligand that potentially binds to all three versions of the receptor structure.</p></sec></sec><sec id="Sec9"><title>Conclusion</title><p id="Par40">The choice of receptor structure is essential for the quality of a computational ligand screening experiment. We have demonstrated that differences in the secondary structure within receptor models of the RNA-depended RNA-polymerase of the tick-borne encephalitis virus and minor differences like the orientation of a single side chain may drastically affect the binding of drug ligands. The structural differences directly influence the size of binding pockets, the orientation and location of bound ligands, and, thus, the effect a ligand might have on the protein&#x02019;s functionality.</p><p id="Par41">We have computationally constructed three different receptor structures with different modeling tools and compared their susceptibility to 2000 potential drug molecules. From the docking stage, the 50 best-performing ligands advanced to the molecular dynamics stage. While 17 of these best-performing ligands could be found across all three different receptor models, no ligand was among the best-performing ligands for all the three investigated structures after the MD stage. The results indicate that without endowing any level of realism on neither the Swiss Model-generated structure, nor the AlphaFold-generated structure, nor their hybrid variant, special care should be taken as a single model could lead to inconsistent results and should not be taken as the all-truth without further study. Additionally, all ligands could be compared regarding their physiochemical properties or their closest residues in the different receptor structures after each stage in ALISE&#x02019;s virtual screening workflow, which would go beyond a study focusing on important structural differences to drug binding in receptor structures.</p><p id="Par42">As a silver lining, however, the ligand with the PubChem ID 21910880 turned out to be structurally identical to the ligand with the PubChem ID 132074004, except for a mirrored oxygen. If one considers these two highly similar compounds, a single potential drug molecule is identified which is robust over all three different receptor models and binds in all of them. Thus, it might be feasible to test the ligand with the PubChem ID 132074004 experimentally, as its performance is close to independent of the structure model. The ligand with the PubChem ID 10302205 performs robustly in two of the three models. In summary, without trusting the physiological realism of the receptor structures, the ligands 10302205 and 21910880 might be feasible candidates for further testing as potential treatments of the TBE.</p><p id="Par43">Overall, trust in a receptor structure is hard earned. We demonstrated the effects of differences in receptors on the binding of drug molecules. Therefore, the results of virtual screening can only be trusted as far as the receptor structure model.</p></sec><sec id="Sec10" sec-type="supplementary-material"><title>Supplementary Information</title><p>Below is the link to the electronic supplementary material.<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="11030_2024_10850_MOESM1_ESM.pdf"><caption><p>Supplementary file 1 (pdf 493 KB)</p></caption></media></supplementary-material></p></sec></body><back><fn-group><fn><p><bold>Publisher's Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><notes notes-type="author-contribution"><title>Author contributions</title><p>FF contributed toward conceptualization, methodology, validation, investigation, writing&#x02014;original draft, and visualization. JH contributed toward validation, software, and writing&#x02014;review and editing. IAS contributed toward resources, data curation, writing&#x02014;review and editing, project administration, and funding acquisition. FS contributed toward conceptualization, writing&#x02014;original draft, visualization, and supervision.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>Open Access funding enabled and organized by Projekt DEAL. The authors would like to thank the Volkswagen Foundation (Lichtenberg Professorship to IAS), the Deutsche Forschungsgemeinschaft (DFG; GRK1885: Molecular Basis of Sensory Biology, SFB 1372: Magnetoreception and Navigation in Vertebrates, and HYP*MOL: Hyperpolarization in molecular systems (TRR386/1-2023)), the Ministry for Science and Culture of Lower Saxony (Simulations Meet Experiments on the Nanoscale: Opening up the Quantum World to Artificial Intelligence (SMART), Dynamik auf der Nanoskala: Von koh&#x000e4;renten Elementarprozessen zur Funktionalit&#x000e4;t (DyNano)), and the Novo Nordisk Foundation (Grant No. NNF22OC0079182). Computational resources for the simulations were provided by the HPC Cluster ROSA, located at the University of Oldenburg (Germany) and funded by the DFG through its Major Research Instrumentation Programme (INST 184/225-1 FUGG) and the Ministry of Science and Culture (MWK) of the Lower Saxony State. The authors also gratefully acknowledge the computing time granted by the Resource Allocation Board and provided on the supercomputer Lise and Emmy at NHR@ZIB and NHR@ G&#x000f6;ttingen as part of the NHR infrastructure. The calculations for thisnresearch were conducted with computing resources he project nip00058.</p></notes><notes notes-type="data-availability"><title>Data availability</title><p>Data supporting the findings of this study are available upon reasonable request. Requests for access to the data should be directed to Ilia A. Solov&#x02019;yov (ilia.solovyov@uni-oldenburg.de). The data are not publicly available due to the amount of data and licensing on third party software for non-academic users.</p></notes><notes notes-type="data-availability"><title>Code availability</title><p>All used programs are cited. Some programs contain proprietary elements, which are not free for non-academic users.</p></notes><notes><title>Declarations</title><notes id="FPar1" notes-type="COI-statement"><title>Conflict of interest</title><p id="Par49">The authors have no conflict of interest to declare that are relevant to the content of this article.</p></notes><notes id="FPar2"><title>Ethical approval</title><p id="Par50">Not applicable.</p></notes><notes id="FPar3"><title>Consent to participate</title><p id="Par51">Not applicable.</p></notes><notes id="FPar4"><title>Consent for publication</title><p id="Par52">Not applicable.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name><surname>Ruzek</surname><given-names>D</given-names></name><name><surname>Av&#x00161;i&#x0010d; &#x0017d;upanc</surname><given-names>T</given-names></name><name><surname>Borde</surname><given-names>J</given-names></name><etal/></person-group><article-title>Tick-borne encephalitis in Europe and Russia: review of pathogenesis, clinical features, therapy, and vaccines</article-title><source>Antiviral Res</source><year>2019</year><volume>164</volume><fpage>23</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1016/j.antiviral.2019.01.014</pub-id><pub-id pub-id-type="pmid">30710567</pub-id>
</element-citation><mixed-citation id="mc-CR1" publication-type="journal">Ruzek D, Av&#x00161;i&#x0010d; &#x0017d;upanc T, Borde J et al (2019) Tick-borne encephalitis in Europe and Russia: review of pathogenesis, clinical features, therapy, and vaccines. Antiviral Res 164:23&#x02013;51. 10.1016/j.antiviral.2019.01.014<pub-id pub-id-type="pmid">30710567</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR2"><label>2.</label><mixed-citation publication-type="other">Surveillance report. tick-borne encephalitis&#x02014;annual epidemiological report for 2020. <ext-link ext-link-type="uri" xlink:href="https://www.ecdc.europa.eu/sites/default/files/documents/Tick-borne-encephalitis-annual-epidemiological-report-2022.pdf">https://www.ecdc.europa.eu/sites/default/files/documents/Tick-borne-encephalitis-annual-epidemiological-report-2022.pdf</ext-link>. Accessed 27 July 2023</mixed-citation></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name><surname>Gritsun</surname><given-names>T</given-names></name><name><surname>Lashkevich</surname><given-names>V</given-names></name><name><surname>Gould</surname><given-names>E</given-names></name></person-group><article-title>Tick-borne encephalitis</article-title><source>Antiviral Res</source><year>2003</year><volume>57</volume><issue>1</issue><fpage>129</fpage><lpage>146</lpage><pub-id pub-id-type="doi">10.1016/S0166-3542(02)00206-1</pub-id><pub-id pub-id-type="pmid">12615309</pub-id>
</element-citation><mixed-citation id="mc-CR3" publication-type="journal">Gritsun T, Lashkevich V, Gould E (2003) Tick-borne encephalitis. Antiviral Res 57(1):129&#x02013;146. 10.1016/S0166-3542(02)00206-1<pub-id pub-id-type="pmid">12615309</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><mixed-citation publication-type="other">Centers for Disease Control and Prevention (2023) Tick-borne encephalitis (TBE)&#x02014;geographic distribution. <ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/tick-borne-encephalitis/geographic-distribution/index.html">https://www.cdc.gov/tick-borne-encephalitis/geographic-distribution/index.html</ext-link>. Accessed 27 July 2023</mixed-citation></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name><surname>Im</surname><given-names>JH</given-names></name><name><surname>Baek</surname><given-names>JH</given-names></name><name><surname>Durey</surname><given-names>A</given-names></name><name><surname>Kwon</surname><given-names>HY</given-names></name><name><surname>Chung</surname><given-names>MH</given-names></name><name><surname>Lee</surname><given-names>JS</given-names></name></person-group><article-title>Geographic distribution of tick-borne encephalitis virus complex</article-title><source>J Vector Borne Dis</source><year>2020</year><volume>57</volume><fpage>14</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.4103/0972-9062.308794</pub-id><pub-id pub-id-type="pmid">33818450</pub-id>
</element-citation><mixed-citation id="mc-CR5" publication-type="journal">Im JH, Baek JH, Durey A, Kwon HY, Chung MH, Lee JS (2020) Geographic distribution of tick-borne encephalitis virus complex. J Vector Borne Dis 57:14&#x02013;22. 10.4103/0972-9062.308794<pub-id pub-id-type="pmid">33818450</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><mixed-citation publication-type="other">Seedat J, Winkler M (2023) Aktuelle daten und informationen zu infektionskrankheiten und public health&#x02014;epidemiologisches bulletin. <ext-link ext-link-type="uri" xlink:href="https://www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2023/Ausgaben/09_23.pdf?__blob=publicationFile">https://www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2023/Ausgaben/09_23.pdf?__blob=publicationFile</ext-link>. Accessed 27 July 2023</mixed-citation></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name><surname>Boldescu</surname><given-names>V</given-names></name><name><surname>Behnam</surname><given-names>MAM</given-names></name><name><surname>Vasilakis</surname><given-names>N</given-names></name><name><surname>Klein</surname><given-names>CD</given-names></name></person-group><article-title>Broad-spectrum agents for flaviviral infections: dengue, Zika and beyond</article-title><source>Nat Rev Drug Discov</source><year>2017</year><volume>16</volume><fpage>565</fpage><lpage>586</lpage><pub-id pub-id-type="doi">10.1038/nrd.2017.33</pub-id><pub-id pub-id-type="pmid">28473729</pub-id>
</element-citation><mixed-citation id="mc-CR7" publication-type="journal">Boldescu V, Behnam MAM, Vasilakis N, Klein CD (2017) Broad-spectrum agents for flaviviral infections: dengue, Zika and beyond. Nat Rev Drug Discov 16:565&#x02013;586. 10.1038/nrd.2017.33<pub-id pub-id-type="pmid">28473729</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><mixed-citation publication-type="other">World Health Organization (2023) Tick-borne encephalitis. <ext-link ext-link-type="uri" xlink:href="https://www.who.int/health-topics/tick-borne-encephalitis#tab=tab_1">https://www.who.int/health-topics/tick-borne-encephalitis#tab=tab_1</ext-link>. Accessed 27 July 2023</mixed-citation></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name><surname>Lipowski</surname><given-names>D</given-names></name><name><surname>Popiel</surname><given-names>M</given-names></name><name><surname>Perlejewski</surname><given-names>K</given-names></name><etal/></person-group><article-title>A cluster of fatal tick-borne encephalitis virus infection in organ transplant setting</article-title><source>J Infect Dis</source><year>2017</year><volume>215</volume><issue>6</issue><fpage>896</fpage><lpage>901</lpage><pub-id pub-id-type="doi">10.1093/infdis/jix040</pub-id><pub-id pub-id-type="pmid">28453842</pub-id>
</element-citation><mixed-citation id="mc-CR9" publication-type="journal">Lipowski D, Popiel M, Perlejewski K et al (2017) A cluster of fatal tick-borne encephalitis virus infection in organ transplant setting. J Infect Dis 215(6):896&#x02013;901. 10.1093/infdis/jix040<pub-id pub-id-type="pmid">28453842</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>G</given-names></name><name><surname>Gong</surname><given-names>P</given-names></name></person-group><article-title>Crystal structure of the full-length Japanese encephalitis virus NS5 reveals a conserved methyltransferase-polymerase interface</article-title><source>PLoS Pathog</source><year>2013</year><volume>9</volume><issue>8</issue><fpage>e1003549</fpage><pub-id pub-id-type="doi">10.1371/journal.ppat.1003549</pub-id><pub-id pub-id-type="pmid">23950717</pub-id>
</element-citation><mixed-citation id="mc-CR10" publication-type="journal">Lu G, Gong P (2013) Crystal structure of the full-length Japanese encephalitis virus NS5 reveals a conserved methyltransferase-polymerase interface. PLoS Pathog 9(8):e1003549. 10.1371/journal.ppat.1003549<pub-id pub-id-type="pmid">23950717</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name><surname>Upadhyay</surname><given-names>AK</given-names></name><name><surname>Cyr</surname><given-names>M</given-names></name><name><surname>Longenecker</surname><given-names>K</given-names></name><name><surname>Tripathi</surname><given-names>R</given-names></name><name><surname>Sun</surname><given-names>C</given-names></name><name><surname>Kempf</surname><given-names>DJ</given-names></name></person-group><article-title>Crystal structure of full-length Zika virus NS5 protein reveals a conformation similar to Japanese encephalitis virus NS5</article-title><source>Acta Crystallogr Sect F Struct Biol Commun</source><year>2017</year><volume>73</volume><issue>Pt 3</issue><fpage>116</fpage><lpage>122</lpage><pub-id pub-id-type="doi">10.1107/S2053230X17001601</pub-id><pub-id pub-id-type="pmid">28291746</pub-id>
</element-citation><mixed-citation id="mc-CR11" publication-type="journal">Upadhyay AK, Cyr M, Longenecker K, Tripathi R, Sun C, Kempf DJ (2017) Crystal structure of full-length Zika virus NS5 protein reveals a conformation similar to Japanese encephalitis virus NS5. Acta Crystallogr Sect F Struct Biol Commun 73(Pt 3):116&#x02013;122. 10.1107/S2053230X17001601<pub-id pub-id-type="pmid">28291746</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name><surname>Badshah</surname><given-names>SL</given-names></name><name><surname>Ahmad</surname><given-names>N</given-names></name><name><surname>Rehman</surname><given-names>AU</given-names></name><name><surname>Khan</surname><given-names>K</given-names></name><name><surname>Ullah</surname><given-names>A</given-names></name><name><surname>Alsayari</surname><given-names>A</given-names></name></person-group><article-title>Molecular docking and simulation of Zika virus NS3 helicase</article-title><source>BMC Chem</source><year>2019</year><volume>13</volume><fpage>67</fpage><pub-id pub-id-type="doi">10.1186/s13065-019-0582-y</pub-id><pub-id pub-id-type="pmid">31384814</pub-id>
</element-citation><mixed-citation id="mc-CR12" publication-type="journal">Badshah SL, Ahmad N, Rehman AU, Khan K, Ullah A, Alsayari A (2019) Molecular docking and simulation of Zika virus NS3 helicase. BMC Chem 13:67. 10.1186/s13065-019-0582-y<pub-id pub-id-type="pmid">31384814</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>KC</given-names></name><name><surname>Lin</surname><given-names>YUF</given-names></name><name><surname>Huang</surname><given-names>ANC</given-names></name></person-group><article-title>Molecular interaction of the antiviral compound CW-33 and its analogues with the NS2B-NS3 protease of the Japanese encephalitis virus</article-title><source>Int J Mol Med</source><year>2019</year><volume>43</volume><fpage>2024</fpage><lpage>2032</lpage><pub-id pub-id-type="doi">10.3892/ijmm.2019.4113</pub-id><pub-id pub-id-type="pmid">30816489</pub-id>
</element-citation><mixed-citation id="mc-CR13" publication-type="journal">Chen KC, Lin YUF, Huang ANC (2019) Molecular interaction of the antiviral compound CW-33 and its analogues with the NS2B-NS3 protease of the Japanese encephalitis virus. Int J Mol Med 43:2024&#x02013;2032. 10.3892/ijmm.2019.4113<pub-id pub-id-type="pmid">30816489</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name><surname>Varadi</surname><given-names>M</given-names></name><name><surname>Anyango</surname><given-names>S</given-names></name><name><surname>Deshpande</surname><given-names>M</given-names></name><etal/></person-group><article-title>AlphaFold protein structure database: massively expanding the structural coverage of protein-sequence space with high-accuracy models</article-title><source>Nucleic Acids Res</source><year>2022</year><volume>50</volume><issue>D1</issue><fpage>D439</fpage><lpage>D444</lpage><pub-id pub-id-type="doi">10.1093/nar/gkab1061</pub-id><pub-id pub-id-type="pmid">34791371</pub-id>
</element-citation><mixed-citation id="mc-CR14" publication-type="journal">Varadi M, Anyango S, Deshpande M et al (2022) AlphaFold protein structure database: massively expanding the structural coverage of protein-sequence space with high-accuracy models. Nucleic Acids Res 50(D1):D439&#x02013;D444. 10.1093/nar/gkab1061<pub-id pub-id-type="pmid">34791371</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name><surname>Hollingsworth</surname><given-names>SA</given-names></name><name><surname>Dror</surname><given-names>RO</given-names></name></person-group><article-title>Molecular dynamics simulation for all</article-title><source>Neuron</source><year>2018</year><volume>99</volume><issue>6</issue><fpage>1129</fpage><lpage>1143</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2018.08.011</pub-id><pub-id pub-id-type="pmid">30236283</pub-id>
</element-citation><mixed-citation id="mc-CR15" publication-type="journal">Hollingsworth SA, Dror RO (2018) Molecular dynamics simulation for all. Neuron 99(6):1129&#x02013;1143. 10.1016/j.neuron.2018.08.011<pub-id pub-id-type="pmid">30236283</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name><surname>Yoshii</surname><given-names>K</given-names></name></person-group><article-title>Epidemiology and pathological mechanisms of tick-borne encephalitis</article-title><source>J Vet Med Sci</source><year>2019</year><volume>81</volume><fpage>343</fpage><lpage>347</lpage><pub-id pub-id-type="doi">10.1292/jvms.18-0373</pub-id><pub-id pub-id-type="pmid">30674746</pub-id>
</element-citation><mixed-citation id="mc-CR16" publication-type="journal">Yoshii K (2019) Epidemiology and pathological mechanisms of tick-borne encephalitis. J Vet Med Sci 81:343&#x02013;347. 10.1292/jvms.18-0373<pub-id pub-id-type="pmid">30674746</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name><surname>Waterhouse</surname><given-names>A</given-names></name><name><surname>Bertoni</surname><given-names>M</given-names></name><name><surname>Bienert</surname><given-names>S</given-names></name><etal/></person-group><article-title>SWISS-MODEL: homology modelling of protein structures and complexes</article-title><source>Nucleic Acids Res</source><year>2018</year><volume>46</volume><issue>W1</issue><fpage>W296</fpage><lpage>W303</lpage><pub-id pub-id-type="doi">10.1093/nar/gky427</pub-id><pub-id pub-id-type="pmid">29788355</pub-id>
</element-citation><mixed-citation id="mc-CR17" publication-type="journal">Waterhouse A, Bertoni M, Bienert S et al (2018) SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Res 46(W1):W296&#x02013;W303. 10.1093/nar/gky427<pub-id pub-id-type="pmid">29788355</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name><surname>Bienert</surname><given-names>S</given-names></name><name><surname>Waterhouse</surname><given-names>A</given-names></name><name><surname>de Beer</surname><given-names>Tjaart A. P</given-names></name><name><surname>Tauriello</surname><given-names>G</given-names></name><name><surname>Studer</surname><given-names>G</given-names></name><name><surname>Bordoli</surname><given-names>L</given-names></name><name><surname>Schwede</surname><given-names>T</given-names></name></person-group><article-title>The SWISS-MODEL repository&#x02014;new features and functionality</article-title><source>Nucleic Acids Res</source><year>2016</year><volume>45</volume><issue>D1</issue><fpage>D313</fpage><lpage>D319</lpage><pub-id pub-id-type="doi">10.1093/nar/gkw1132</pub-id><pub-id pub-id-type="pmid">27899672</pub-id>
</element-citation><mixed-citation id="mc-CR18" publication-type="journal">Bienert S, Waterhouse A, de Beer Tjaart A. P, Tauriello G, Studer G, Bordoli L, Schwede T (2016) The SWISS-MODEL repository&#x02014;new features and functionality. Nucleic Acids Res 45(D1):D313&#x02013;D319. 10.1093/nar/gkw1132<pub-id pub-id-type="pmid">27899672</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name><surname>Guex</surname><given-names>N</given-names></name><name><surname>Peitsch</surname><given-names>MC</given-names></name><name><surname>Schwede</surname><given-names>T</given-names></name></person-group><article-title>Automated comparative protein structure modeling with SWISS-MODEL and Swiss-PdbViewer: a historical perspective</article-title><source>Electrophoresis</source><year>2009</year><volume>30</volume><issue>Suppl 1</issue><fpage>S162</fpage><lpage>73</lpage><pub-id pub-id-type="doi">10.1002/elps.200900140</pub-id><pub-id pub-id-type="pmid">19517507</pub-id>
</element-citation><mixed-citation id="mc-CR19" publication-type="journal">Guex N, Peitsch MC, Schwede T (2009) Automated comparative protein structure modeling with SWISS-MODEL and Swiss-PdbViewer: a historical perspective. Electrophoresis 30(Suppl 1):S162-73. 10.1002/elps.200900140<pub-id pub-id-type="pmid">19517507</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name><surname>Studer</surname><given-names>G</given-names></name><name><surname>Rempfer</surname><given-names>C</given-names></name><name><surname>Waterhouse</surname><given-names>AM</given-names></name><name><surname>Gumienny</surname><given-names>R</given-names></name><name><surname>Haas</surname><given-names>J</given-names></name><name><surname>Schwede</surname><given-names>T</given-names></name></person-group><article-title>QMEANDisCo-distance constraints applied on model quality estimation</article-title><source>Bioinformatics</source><year>2020</year><volume>36</volume><issue>6</issue><fpage>1765</fpage><lpage>1771</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btz828</pub-id><pub-id pub-id-type="pmid">31697312</pub-id>
</element-citation><mixed-citation id="mc-CR20" publication-type="journal">Studer G, Rempfer C, Waterhouse AM, Gumienny R, Haas J, Schwede T (2020) QMEANDisCo-distance constraints applied on model quality estimation. Bioinformatics 36(6):1765&#x02013;1771. 10.1093/bioinformatics/btz828<pub-id pub-id-type="pmid">31697312</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name><surname>Bertoni</surname><given-names>M</given-names></name><name><surname>Kiefer</surname><given-names>F</given-names></name><name><surname>Biasini</surname><given-names>M</given-names></name><name><surname>Bordoli</surname><given-names>L</given-names></name><name><surname>Schwede</surname><given-names>T</given-names></name></person-group><article-title>Modeling protein quaternary structure of homo- and hetero-oligomers beyond binary interactions by homology</article-title><source>Sci Rep</source><year>2017</year><volume>7</volume><issue>1</issue><fpage>10480</fpage><pub-id pub-id-type="doi">10.1038/s41598-017-09654-8</pub-id><pub-id pub-id-type="pmid">28874689</pub-id>
</element-citation><mixed-citation id="mc-CR21" publication-type="journal">Bertoni M, Kiefer F, Biasini M, Bordoli L, Schwede T (2017) Modeling protein quaternary structure of homo- and hetero-oligomers beyond binary interactions by homology. Sci Rep 7(1):10480. 10.1038/s41598-017-09654-8<pub-id pub-id-type="pmid">28874689</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name><surname>Jumper</surname><given-names>J</given-names></name><name><surname>Evans</surname><given-names>R</given-names></name><name><surname>Pritzel</surname><given-names>A</given-names></name><etal/></person-group><article-title>Highly accurate protein structure prediction with AlphaFold</article-title><source>Nature</source><year>2021</year><volume>596</volume><issue>7873</issue><fpage>583</fpage><lpage>589</lpage><pub-id pub-id-type="doi">10.1038/s41586-021-03819-2</pub-id><pub-id pub-id-type="pmid">34265844</pub-id>
</element-citation><mixed-citation id="mc-CR22" publication-type="journal">Jumper J, Evans R, Pritzel A et al (2021) Highly accurate protein structure prediction with AlphaFold. Nature 596(7873):583&#x02013;589. 10.1038/s41586-021-03819-2<pub-id pub-id-type="pmid">34265844</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name><surname>Ahdritz</surname><given-names>G</given-names></name><name><surname>Bouatta</surname><given-names>N</given-names></name><name><surname>Floristean</surname><given-names>C</given-names></name><name><surname>Kadyan</surname><given-names>S</given-names></name><name><surname>Xia</surname><given-names>Q</given-names></name><name><surname>Gerecke</surname><given-names>W</given-names></name><name><surname>O&#x02019;Donnell</surname><given-names>TJ</given-names></name><name><surname>Berenberg</surname><given-names>D</given-names></name><name><surname>Fisk</surname><given-names>I</given-names></name><name><surname>Zanichelli</surname><given-names>N</given-names></name><name><surname>Zhang</surname><given-names>B</given-names></name><name><surname>Nowaczynski</surname><given-names>A</given-names></name><name><surname>Wang</surname><given-names>B</given-names></name><name><surname>Stepniewska-Dziubinska</surname><given-names>MM</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Ojewole</surname><given-names>A</given-names></name><name><surname>Guney</surname><given-names>ME</given-names></name><name><surname>Biderman</surname><given-names>S</given-names></name><name><surname>Watkins</surname><given-names>AM</given-names></name><name><surname>Ra</surname><given-names>S</given-names></name><name><surname>Lorenzo</surname><given-names>PR</given-names></name><name><surname>Nivon</surname><given-names>L</given-names></name><name><surname>Weitzner</surname><given-names>B</given-names></name><name><surname>Ban</surname><given-names>YEA</given-names></name><name><surname>Sorger</surname><given-names>PK</given-names></name><name><surname>Mostaque</surname><given-names>E</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Bonneau</surname><given-names>R</given-names></name><name><surname>AlQuraishi</surname><given-names>M</given-names></name></person-group><article-title>OpenFold: retraining AlphaFold2 yields new insights into its learning mechanisms and capacity for generalization</article-title><source>bioRxiv</source><year>2022</year><pub-id pub-id-type="doi">10.1101/2022.11.20.517210</pub-id></element-citation><mixed-citation id="mc-CR23" publication-type="journal">...Ahdritz G, Bouatta N, Floristean C, Kadyan S, Xia Q, Gerecke W, O&#x02019;Donnell TJ, Berenberg D, Fisk I, Zanichelli N, Zhang B, Nowaczynski A, Wang B, Stepniewska-Dziubinska MM, Zhang S, Ojewole A, Guney ME, Biderman S, Watkins AM, Ra S, Lorenzo PR, Nivon L, Weitzner B, Ban YEA, Sorger PK, Mostaque E, Zhang Z, Bonneau R, AlQuraishi M (2022) OpenFold: retraining AlphaFold2 yields new insights into its learning mechanisms and capacity for generalization. bioRxiv. 10.1101/2022.11.20.517210</mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name><surname>Lim</surname><given-names>SP</given-names></name><name><surname>Koh</surname><given-names>JHK</given-names></name><name><surname>Seh</surname><given-names>CC</given-names></name><name><surname>Liew</surname><given-names>CW</given-names></name><name><surname>Davidson</surname><given-names>AD</given-names></name><name><surname>Chua</surname><given-names>LS</given-names></name><name><surname>Chandrasekaran</surname><given-names>R</given-names></name><name><surname>Cornvik</surname><given-names>TC</given-names></name><name><surname>Shi</surname><given-names>P-Y</given-names></name><name><surname>Lescar</surname><given-names>J</given-names></name></person-group><article-title>A crystal structure of the dengue virus non-structural protein 5 (NS5) polymerase delineates interdomain amino acid residues that enhance its thermostability and de novo initiation activities</article-title><source>J Biol Chem</source><year>2013</year><volume>288</volume><issue>43</issue><fpage>31105</fpage><lpage>31114</lpage><pub-id pub-id-type="doi">10.1074/jbc.M113.508606</pub-id><pub-id pub-id-type="pmid">24025331</pub-id>
</element-citation><mixed-citation id="mc-CR24" publication-type="journal">Lim SP, Koh JHK, Seh CC, Liew CW, Davidson AD, Chua LS, Chandrasekaran R, Cornvik TC, Shi P-Y, Lescar J (2013) A crystal structure of the dengue virus non-structural protein 5 (NS5) polymerase delineates interdomain amino acid residues that enhance its thermostability and de novo initiation activities. J Biol Chem 288(43):31105&#x02013;31114. 10.1074/jbc.M113.508606<pub-id pub-id-type="pmid">24025331</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>B</given-names></name><name><surname>Yi</surname><given-names>G</given-names></name><name><surname>Du</surname><given-names>F</given-names></name><name><surname>Chuang</surname><given-names>Y-C</given-names></name><name><surname>Vaughan</surname><given-names>RC</given-names></name><name><surname>Sankaran</surname><given-names>B</given-names></name><name><surname>Kao</surname><given-names>C-C</given-names></name><name><surname>Li</surname><given-names>P</given-names></name></person-group><article-title>Structure and function of the Zika virus full-length NS5 protein</article-title><source>Nat Commun</source><year>2017</year><pub-id pub-id-type="doi">10.1038/ncomms14762</pub-id><pub-id pub-id-type="pmid">29273768</pub-id>
</element-citation><mixed-citation id="mc-CR25" publication-type="journal">Zhao B, Yi G, Du F, Chuang Y-C, Vaughan RC, Sankaran B, Kao C-C, Li P (2017) Structure and function of the Zika virus full-length NS5 protein. Nat Commun. 10.1038/ncomms14762<pub-id pub-id-type="pmid">29273768</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR26"><label>26.</label><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><name><surname>Jacobsen</surname><given-names>L</given-names></name><name><surname>Hungerland</surname><given-names>J</given-names></name><name><surname>Ba&#x0010d;i&#x00107;</surname><given-names>V</given-names></name><name><surname>Gerhards</surname><given-names>L</given-names></name><name><surname>Schuhmann</surname><given-names>F</given-names></name><name><surname>Solov&#x02019;yov</surname><given-names>IA</given-names></name></person-group><article-title>Introducing the automated ligand searcher (ALISE)</article-title><source>J Chem Inf Model</source><year>2023</year><volume>63</volume><fpage>7518</fpage><lpage>7528</lpage><pub-id pub-id-type="doi">10.1021/acs.jcim.3c01317</pub-id><pub-id pub-id-type="pmid">37983165</pub-id>
</element-citation><mixed-citation id="mc-CR26" publication-type="journal">Jacobsen L, Hungerland J, Ba&#x0010d;i&#x00107; V, Gerhards L, Schuhmann F, Solov&#x02019;yov IA (2023) Introducing the automated ligand searcher (ALISE). J Chem Inf Model 63:7518&#x02013;7528. 10.1021/acs.jcim.3c01317<pub-id pub-id-type="pmid">37983165</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR27"><label>27.</label><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name><surname>Korol</surname><given-names>V</given-names></name><name><surname>Husen</surname><given-names>P</given-names></name><name><surname>Sjulstok</surname><given-names>E</given-names></name><name><surname>Nielsen</surname><given-names>C</given-names></name><name><surname>Friis</surname><given-names>I</given-names></name><name><surname>Frederiksen</surname><given-names>A</given-names></name><name><surname>Salo</surname><given-names>AB</given-names></name><name><surname>Solov&#x02019;yov</surname><given-names>IA</given-names></name></person-group><article-title>Introducing VIKING: a novel misc platform for multiscale modeling</article-title><source>ACS Omega</source><year>2020</year><volume>5</volume><issue>2</issue><fpage>1254</fpage><lpage>1260</lpage><pub-id pub-id-type="doi">10.1021/acsomega.9b03802</pub-id><pub-id pub-id-type="pmid">31984283</pub-id>
</element-citation><mixed-citation id="mc-CR27" publication-type="journal">Korol V, Husen P, Sjulstok E, Nielsen C, Friis I, Frederiksen A, Salo AB, Solov&#x02019;yov IA (2020) Introducing VIKING: a novel misc platform for multiscale modeling. ACS Omega 5(2):1254&#x02013;1260. 10.1021/acsomega.9b03802<pub-id pub-id-type="pmid">31984283</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR28"><label>28.</label><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Jing</surname><given-names>X</given-names></name><name><surname>Yi</surname><given-names>W</given-names></name><name><surname>Li</surname><given-names>XD</given-names></name><name><surname>Yao</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>B</given-names></name><name><surname>Zheng</surname><given-names>Z</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Gong</surname><given-names>P</given-names></name></person-group><article-title>Crystal structure of a tick-borne flavivirus RNA-dependent RNA polymerase suggests a host adaptation hotspot in RNA viruses</article-title><source>Nucleic Acids Res</source><year>2021</year><volume>49</volume><issue>3</issue><fpage>1567</fpage><lpage>1580</lpage><pub-id pub-id-type="doi">10.1093/nar/gkaa1250</pub-id><pub-id pub-id-type="pmid">33406260</pub-id>
</element-citation><mixed-citation id="mc-CR28" publication-type="journal">Yang J, Jing X, Yi W, Li XD, Yao C, Zhang B, Zheng Z, Wang H, Gong P (2021) Crystal structure of a tick-borne flavivirus RNA-dependent RNA polymerase suggests a host adaptation hotspot in RNA viruses. Nucleic Acids Res 49(3):1567&#x02013;1580. 10.1093/nar/gkaa1250<pub-id pub-id-type="pmid">33406260</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR29"><label>29.</label><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>KH</given-names></name><name><surname>Rossmann</surname><given-names>MG</given-names></name></person-group><article-title>RNA-dependent RNA polymerases from flaviviridae</article-title><source>Curr Opin Struct Biol</source><year>2009</year><volume>19</volume><issue>6</issue><fpage>746</fpage><lpage>751</lpage><pub-id pub-id-type="doi">10.1016/j.sbi.2009.10.015</pub-id><pub-id pub-id-type="pmid">19914821</pub-id>
</element-citation><mixed-citation id="mc-CR29" publication-type="journal">Choi KH, Rossmann MG (2009) RNA-dependent RNA polymerases from flaviviridae. Curr Opin Struct Biol 19(6):746&#x02013;751. 10.1016/j.sbi.2009.10.015<pub-id pub-id-type="pmid">19914821</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR30"><label>30.</label><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name><surname>Berman</surname><given-names>HM</given-names></name><name><surname>Westbrook</surname><given-names>J</given-names></name><name><surname>Feng</surname><given-names>Z</given-names></name><name><surname>Gilliland</surname><given-names>G</given-names></name><name><surname>Bhat</surname><given-names>TN</given-names></name><name><surname>Weissig</surname><given-names>H</given-names></name><name><surname>Shindyalov</surname><given-names>IN</given-names></name><name><surname>Bourne</surname><given-names>PE</given-names></name></person-group><article-title>The Protein Data Bank</article-title><source>Nucleic Acids Res</source><year>2000</year><volume>28</volume><issue>1</issue><fpage>235</fpage><lpage>242</lpage><pub-id pub-id-type="doi">10.1093/nar/28.1.235</pub-id><pub-id pub-id-type="pmid">10592235</pub-id>
</element-citation><mixed-citation id="mc-CR30" publication-type="journal">Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE (2000) The Protein Data Bank. Nucleic Acids Res 28(1):235&#x02013;242. 10.1093/nar/28.1.235<pub-id pub-id-type="pmid">10592235</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR31"><label>31.</label><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name><surname>Bordoli</surname><given-names>L</given-names></name><name><surname>Kiefer</surname><given-names>F</given-names></name><name><surname>Arnold</surname><given-names>K</given-names></name><name><surname>Benkert</surname><given-names>P</given-names></name><name><surname>Battey</surname><given-names>J</given-names></name><name><surname>Schwede</surname><given-names>T</given-names></name></person-group><article-title>Protein structure homology modeling using SWISS-MODEL workspace</article-title><source>Nat Protoc</source><year>2009</year><volume>4</volume><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1038/nprot.2008.197</pub-id><pub-id pub-id-type="pmid">19131951</pub-id>
</element-citation><mixed-citation id="mc-CR31" publication-type="journal">Bordoli L, Kiefer F, Arnold K, Benkert P, Battey J, Schwede T (2009) Protein structure homology modeling using SWISS-MODEL workspace. Nat Protoc 4:1&#x02013;13. 10.1038/nprot.2008.197<pub-id pub-id-type="pmid">19131951</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR32"><label>32.</label><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name><surname>Barragan</surname><given-names>AM</given-names></name><name><surname>Crofts</surname><given-names>AR</given-names></name><name><surname>Schulten</surname><given-names>K</given-names></name><name><surname>Solov&#x02019;yov</surname><given-names>IA</given-names></name></person-group><article-title>Identification of ubiquinol binding motifs at the Qo-site of the cytochrome bc1 complex</article-title><source>J Phys Chem B</source><year>2015</year><volume>119</volume><issue>2</issue><fpage>433</fpage><lpage>447</lpage><pub-id pub-id-type="doi">10.1021/jp510022w</pub-id><pub-id pub-id-type="pmid">25372183</pub-id>
</element-citation><mixed-citation id="mc-CR32" publication-type="journal">Barragan AM, Crofts AR, Schulten K, Solov&#x02019;yov IA (2015) Identification of ubiquinol binding motifs at the Qo-site of the cytochrome bc1 complex. J Phys Chem B 119(2):433&#x02013;447. 10.1021/jp510022w<pub-id pub-id-type="pmid">25372183</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR33"><label>33.</label><mixed-citation publication-type="other">Hopkins E, Sanvictores T, Sharma S (2022) Physiology, acid base balance. <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK507807/">https://www.ncbi.nlm.nih.gov/books/NBK507807/</ext-link>. Accessed 14 Apr 2023</mixed-citation></ref><ref id="CR34"><label>34.</label><citation-alternatives><element-citation id="ec-CR34" publication-type="journal"><person-group person-group-type="author"><name><surname>Olsson</surname><given-names>MHM</given-names></name><name><surname>S&#x000f8;ndergaard</surname><given-names>CR</given-names></name><name><surname>Rostkowski</surname><given-names>M</given-names></name><name><surname>Jensen</surname><given-names>JH</given-names></name></person-group><article-title>Propka3: consistent treatment of internal and surface residues in empirical pka predictions</article-title><source>J Chem Theory Comput</source><year>2011</year><volume>7</volume><issue>2</issue><fpage>525</fpage><lpage>537</lpage><pub-id pub-id-type="doi">10.1021/ct100578z</pub-id><pub-id pub-id-type="pmid">26596171</pub-id>
</element-citation><mixed-citation id="mc-CR34" publication-type="journal">Olsson MHM, S&#x000f8;ndergaard CR, Rostkowski M, Jensen JH (2011) Propka3: consistent treatment of internal and surface residues in empirical pka predictions. J Chem Theory Comput 7(2):525&#x02013;537. 10.1021/ct100578z<pub-id pub-id-type="pmid">26596171</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR35"><label>35.</label><citation-alternatives><element-citation id="ec-CR35" publication-type="journal"><person-group person-group-type="author"><name><surname>S&#x000f8;ndergaard</surname><given-names>CR</given-names></name><name><surname>Olsson</surname><given-names>MHM</given-names></name><name><surname>Rostkowski</surname><given-names>M</given-names></name><name><surname>Jensen</surname><given-names>JH</given-names></name></person-group><article-title>Improved treatment of ligands and coupling effects in empirical calculation and rationalization of pka values</article-title><source>J Chem Theory Comput</source><year>2011</year><volume>7</volume><issue>7</issue><fpage>2284</fpage><lpage>2295</lpage><pub-id pub-id-type="doi">10.1021/ct200133y</pub-id><pub-id pub-id-type="pmid">26606496</pub-id>
</element-citation><mixed-citation id="mc-CR35" publication-type="journal">S&#x000f8;ndergaard CR, Olsson MHM, Rostkowski M, Jensen JH (2011) Improved treatment of ligands and coupling effects in empirical calculation and rationalization of pka values. J Chem Theory Comput 7(7):2284&#x02013;2295. 10.1021/ct200133y<pub-id pub-id-type="pmid">26606496</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR36"><label>36.</label><citation-alternatives><element-citation id="ec-CR36" publication-type="journal"><person-group person-group-type="author"><name><surname>Phillips</surname><given-names>JC</given-names></name><name><surname>Hardy</surname><given-names>DJ</given-names></name><name><surname>Maia</surname><given-names>JDC</given-names></name><etal/></person-group><article-title>Scalable molecular dynamics on CPU and GPU architectures with NAMD</article-title><source>J Chem Phys</source><year>2020</year><volume>153</volume><issue>4</issue><fpage>044130</fpage><pub-id pub-id-type="doi">10.1063/5.0014475</pub-id><pub-id pub-id-type="pmid">32752662</pub-id>
</element-citation><mixed-citation id="mc-CR36" publication-type="journal">Phillips JC, Hardy DJ, Maia JDC et al (2020) Scalable molecular dynamics on CPU and GPU architectures with NAMD. J Chem Phys 153(4):044130. 10.1063/5.0014475<pub-id pub-id-type="pmid">32752662</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR37"><label>37.</label><citation-alternatives><element-citation id="ec-CR37" publication-type="journal"><person-group person-group-type="author"><name><surname>Phillips</surname><given-names>JC</given-names></name><name><surname>Braun</surname><given-names>R</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Gumbart</surname><given-names>J</given-names></name><name><surname>Tajkhorshid</surname><given-names>E</given-names></name><name><surname>Villa</surname><given-names>E</given-names></name><name><surname>Chipot</surname><given-names>C</given-names></name><name><surname>Skeel</surname><given-names>RD</given-names></name><name><surname>Kal&#x000e9;</surname><given-names>L</given-names></name><name><surname>Schulten</surname><given-names>K</given-names></name></person-group><article-title>Scalable molecular dynamics with NAMD</article-title><source>J Comput Chem</source><year>2005</year><volume>26</volume><issue>16</issue><fpage>1781</fpage><lpage>1802</lpage><pub-id pub-id-type="doi">10.1002/jcc.20289</pub-id><pub-id pub-id-type="pmid">16222654</pub-id>
</element-citation><mixed-citation id="mc-CR37" publication-type="journal">Phillips JC, Braun R, Wang W, Gumbart J, Tajkhorshid E, Villa E, Chipot C, Skeel RD, Kal&#x000e9; L, Schulten K (2005) Scalable molecular dynamics with NAMD. J Comput Chem 26(16):1781&#x02013;1802. 10.1002/jcc.20289<pub-id pub-id-type="pmid">16222654</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR38"><label>38.</label><mixed-citation publication-type="other">Humphrey W, Dalke A, Schulten K (1996) VMD: visual molecular dynamics. J Mol Graph Model 14(1):33&#x02013;38, 27&#x02013;28. 10.1016/0263-7855(96)00018-5</mixed-citation></ref><ref id="CR39"><label>39.</label><citation-alternatives><element-citation id="ec-CR39" publication-type="journal"><person-group person-group-type="author"><name><surname>Brooks</surname><given-names>BR</given-names></name><name><surname>Brooks</surname><given-names>CL</given-names><suffix>III</suffix></name><name><surname>Mackerell</surname><given-names>AD</given-names><suffix>Jr</suffix></name><etal/></person-group><article-title>CHARMM: the biomolecular simulation program</article-title><source>J Comput Chem</source><year>2009</year><volume>30</volume><issue>10</issue><fpage>1545</fpage><lpage>1614</lpage><pub-id pub-id-type="doi">10.1002/jcc.21287</pub-id><pub-id pub-id-type="pmid">19444816</pub-id>
</element-citation><mixed-citation id="mc-CR39" publication-type="journal">Brooks BR, Brooks CL III, Mackerell AD Jr et al (2009) CHARMM: the biomolecular simulation program. J Comput Chem 30(10):1545&#x02013;1614. 10.1002/jcc.21287<pub-id pub-id-type="pmid">19444816</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR40"><label>40.</label><citation-alternatives><element-citation id="ec-CR40" publication-type="journal"><person-group person-group-type="author"><name><surname>MacKerell</surname><given-names>AD</given-names></name><name><surname>Bashford</surname><given-names>D</given-names></name><name><surname>Bellott</surname><given-names>M</given-names></name><etal/></person-group><article-title>All-atom empirical potential for molecular modeling and dynamics studies of proteins</article-title><source>J Phys Chem B</source><year>1998</year><volume>102</volume><issue>18</issue><fpage>3586</fpage><lpage>3616</lpage><pub-id pub-id-type="doi">10.1021/jp973084f</pub-id><pub-id pub-id-type="pmid">24889800</pub-id>
</element-citation><mixed-citation id="mc-CR40" publication-type="journal">MacKerell AD, Bashford D, Bellott M et al (1998) All-atom empirical potential for molecular modeling and dynamics studies of proteins. J Phys Chem B 102(18):3586&#x02013;3616. 10.1021/jp973084f<pub-id pub-id-type="pmid">24889800</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR41"><label>41.</label><citation-alternatives><element-citation id="ec-CR41" publication-type="journal"><person-group person-group-type="author"><name><surname>MacKerell</surname><given-names>AD</given-names><suffix>Jr</suffix></name><name><surname>Feig</surname><given-names>M</given-names></name><name><surname>Brooks</surname><given-names>CL</given-names><suffix>III</suffix></name></person-group><article-title>Improved treatment of the protein backbone in empirical force fields</article-title><source>J Am Chem Soc</source><year>2004</year><volume>126</volume><fpage>698</fpage><lpage>699</lpage><pub-id pub-id-type="doi">10.1021/ja036959e</pub-id><pub-id pub-id-type="pmid">14733527</pub-id>
</element-citation><mixed-citation id="mc-CR41" publication-type="journal">MacKerell AD Jr, Feig M, Brooks CL III (2004) Improved treatment of the protein backbone in empirical force fields. J Am Chem Soc 126:698&#x02013;699. 10.1021/ja036959e<pub-id pub-id-type="pmid">14733527</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR42"><label>42.</label><citation-alternatives><element-citation id="ec-CR42" publication-type="journal"><person-group person-group-type="author"><name><surname>Bajusz</surname><given-names>D</given-names></name><name><surname>R&#x000e1;cz</surname><given-names>A</given-names></name><name><surname>H&#x000e9;berger</surname><given-names>K</given-names></name></person-group><article-title>Why is Tanimoto index an appropriate choice for fingerprint-based similarity calculations ?</article-title><source>J Cheminform</source><year>2015</year><volume>7</volume><fpage>20</fpage><pub-id pub-id-type="doi">10.1186/s13321-015-0069-3</pub-id><pub-id pub-id-type="pmid">26052348</pub-id>
</element-citation><mixed-citation id="mc-CR42" publication-type="journal">Bajusz D, R&#x000e1;cz A, H&#x000e9;berger K (2015) Why is Tanimoto index an appropriate choice for fingerprint-based similarity calculations&#x0202f;? J Cheminform 7:20. 10.1186/s13321-015-0069-3<pub-id pub-id-type="pmid">26052348</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR43"><label>43.</label><citation-alternatives><element-citation id="ec-CR43" publication-type="journal"><person-group person-group-type="author"><name><surname>Ellingson</surname><given-names>SR</given-names></name><name><surname>Smith</surname><given-names>JC</given-names></name><name><surname>Baudry</surname><given-names>J</given-names></name></person-group><article-title>VinaMPI: facilitating multiple receptor high-throughput virtual docking on high-performance computers</article-title><source>J Comput Chem</source><year>2013</year><volume>34</volume><issue>25</issue><fpage>2212</fpage><lpage>2221</lpage><pub-id pub-id-type="doi">10.1002/jcc.23367</pub-id><pub-id pub-id-type="pmid">23813626</pub-id>
</element-citation><mixed-citation id="mc-CR43" publication-type="journal">Ellingson SR, Smith JC, Baudry J (2013) VinaMPI: facilitating multiple receptor high-throughput virtual docking on high-performance computers. J Comput Chem 34(25):2212&#x02013;2221. 10.1002/jcc.23367<pub-id pub-id-type="pmid">23813626</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR44"><label>44.</label><citation-alternatives><element-citation id="ec-CR44" publication-type="journal"><person-group person-group-type="author"><name><surname>Morris</surname><given-names>GM</given-names></name><name><surname>Huey</surname><given-names>R</given-names></name><name><surname>Lindstrom</surname><given-names>W</given-names></name><name><surname>Sanner</surname><given-names>MF</given-names></name><name><surname>Belew</surname><given-names>RK</given-names></name><name><surname>Goodsell</surname><given-names>DS</given-names></name><name><surname>Olson</surname><given-names>AJ</given-names></name></person-group><article-title>Software news and updates AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility</article-title><source>J Comput Chem</source><year>2009</year><volume>30</volume><fpage>2785</fpage><lpage>2791</lpage><pub-id pub-id-type="doi">10.1002/jcc</pub-id><pub-id pub-id-type="pmid">19399780</pub-id>
</element-citation><mixed-citation id="mc-CR44" publication-type="journal">Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, Olson AJ (2009) Software news and updates AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem 30:2785&#x02013;2791. 10.1002/jcc<pub-id pub-id-type="pmid">19399780</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR45"><label>45.</label><citation-alternatives><element-citation id="ec-CR45" publication-type="journal"><person-group person-group-type="author"><name><surname>Boyle</surname><given-names>NMO</given-names></name><name><surname>Banck</surname><given-names>M</given-names></name><name><surname>James</surname><given-names>CA</given-names></name><name><surname>Morley</surname><given-names>C</given-names></name><name><surname>Vandermeersch</surname><given-names>T</given-names></name><name><surname>Hutchison</surname><given-names>GR</given-names></name></person-group><article-title>Open Babel: an open chemical toolbox</article-title><source>J Cheminform</source><year>2011</year><volume>3</volume><fpage>33</fpage><pub-id pub-id-type="doi">10.1186/1758-2946-3-33</pub-id><pub-id pub-id-type="pmid">21982300</pub-id>
</element-citation><mixed-citation id="mc-CR45" publication-type="journal">Boyle NMO, Banck M, James CA, Morley C, Vandermeersch T, Hutchison GR (2011) Open Babel: an open chemical toolbox. J Cheminform 3:33<pub-id pub-id-type="pmid">21982300</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR46"><label>46.</label><citation-alternatives><element-citation id="ec-CR46" publication-type="journal"><person-group person-group-type="author"><name><surname>Genheden</surname><given-names>S</given-names></name><name><surname>Ryde</surname><given-names>U</given-names></name></person-group><article-title>The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities</article-title><source>Expert Opin Drug Discov</source><year>2015</year><volume>10</volume><issue>5</issue><fpage>449</fpage><lpage>461</lpage><pub-id pub-id-type="doi">10.1517/17460441.2015.1032936</pub-id><pub-id pub-id-type="pmid">25835573</pub-id>
</element-citation><mixed-citation id="mc-CR46" publication-type="journal">Genheden S, Ryde U (2015) The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities. Expert Opin Drug Discov 10(5):449&#x02013;461. 10.1517/17460441.2015.1032936<pub-id pub-id-type="pmid">25835573</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR47"><label>47.</label><citation-alternatives><element-citation id="ec-CR47" publication-type="journal"><person-group person-group-type="author"><name><surname>Vanommeslaeghe</surname><given-names>K</given-names></name><name><surname>Hatcher</surname><given-names>E</given-names></name><name><surname>Acharya</surname><given-names>C</given-names></name><etal/></person-group><article-title>CHARMM general force field: a force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields</article-title><source>J Comput Chem</source><year>2010</year><volume>31</volume><issue>4</issue><fpage>671</fpage><lpage>690</lpage><pub-id pub-id-type="doi">10.1002/jcc.21367</pub-id><pub-id pub-id-type="pmid">19575467</pub-id>
</element-citation><mixed-citation id="mc-CR47" publication-type="journal">Vanommeslaeghe K, Hatcher E, Acharya C et al (2010) CHARMM general force field: a force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields. J Comput Chem 31(4):671&#x02013;690. 10.1002/jcc.21367<pub-id pub-id-type="pmid">19575467</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR48"><label>48.</label><mixed-citation publication-type="other">Foloppe N, MacKerell AD (2000) All-atom empirical force field for nucleic acids: I. Parameter optimization based on small molecule and condensed phase macromolecular target data. J Comput Chem 21(2):86&#x02013;104. 10.1002/(SICI)1096-987X(20000130)21:2h86::AID-JCC2i3.0.CO;2-G</mixed-citation></ref><ref id="CR49"><label>49.</label><citation-alternatives><element-citation id="ec-CR49" publication-type="journal"><person-group person-group-type="author"><name><surname>Best</surname><given-names>RB</given-names></name><name><surname>Zhu</surname><given-names>X</given-names></name><name><surname>Shim</surname><given-names>J</given-names></name><name><surname>Lopes</surname><given-names>PE</given-names></name><name><surname>Mittal</surname><given-names>J</given-names></name><name><surname>Feig</surname><given-names>M</given-names></name><name><surname>MacKerell</surname><given-names>AD</given-names></name></person-group><article-title>Optimization of the additive CHARMM all-atom protein force field targeting improved sampling of the backbone <inline-formula id="IEq28"><alternatives><tex-math id="M11">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\phi $$\end{document}</tex-math><mml:math id="M12"><mml:mi>&#x003d5;</mml:mi></mml:math><inline-graphic xlink:href="11030_2024_10850_Article_IEq28.gif"/></alternatives></inline-formula>, <inline-formula id="IEq29"><alternatives><tex-math id="M13">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\psi $$\end{document}</tex-math><mml:math id="M14"><mml:mi>&#x003c8;</mml:mi></mml:math><inline-graphic xlink:href="11030_2024_10850_Article_IEq29.gif"/></alternatives></inline-formula> and side-chain <inline-formula id="IEq30"><alternatives><tex-math id="M15">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\chi $$\end{document}</tex-math><mml:math id="M16"><mml:mi>&#x003c7;</mml:mi></mml:math><inline-graphic xlink:href="11030_2024_10850_Article_IEq30.gif"/></alternatives></inline-formula>1 and <inline-formula id="IEq31"><alternatives><tex-math id="M17">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\chi $$\end{document}</tex-math><mml:math id="M18"><mml:mi>&#x003c7;</mml:mi></mml:math><inline-graphic xlink:href="11030_2024_10850_Article_IEq31.gif"/></alternatives></inline-formula>2 dihedral angles</article-title><source>J Chem Theory Comput</source><year>2012</year><volume>8</volume><issue>9</issue><fpage>3257</fpage><lpage>3273</lpage><pub-id pub-id-type="doi">10.1021/ct300400x</pub-id><pub-id pub-id-type="pmid">23341755</pub-id>
</element-citation><mixed-citation id="mc-CR49" publication-type="journal">Best RB, Zhu X, Shim J, Lopes PE, Mittal J, Feig M, MacKerell AD (2012) Optimization of the additive CHARMM all-atom protein force field targeting improved sampling of the backbone <inline-graphic xlink:href="11030_2024_10850_Article_IEq32.gif"/>, <inline-graphic xlink:href="11030_2024_10850_Article_IEq33.gif"/> and side-chain <inline-graphic xlink:href="11030_2024_10850_Article_IEq34.gif"/>1 and <inline-graphic xlink:href="11030_2024_10850_Article_IEq35.gif"/>2 dihedral angles. J Chem Theory Comput 8(9):3257&#x02013;3273. 10.1021/ct300400x<pub-id pub-id-type="pmid">23341755</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR50"><label>50.</label><citation-alternatives><element-citation id="ec-CR50" publication-type="journal"><person-group person-group-type="author"><name><surname>Hart</surname><given-names>K</given-names></name><name><surname>Foloppe</surname><given-names>N</given-names></name><name><surname>Baker</surname><given-names>CM</given-names></name><name><surname>Denning</surname><given-names>EJ</given-names></name><name><surname>Nilsson</surname><given-names>L</given-names></name><name><surname>MacKerell</surname><given-names>AD</given-names></name></person-group><article-title>Optimization of the CHARMM additive force field for DNA: improved treatment of the BI/BII conformational equilibrium</article-title><source>J Chem Theory Comput</source><year>2012</year><volume>8</volume><issue>1</issue><fpage>348</fpage><lpage>362</lpage><pub-id pub-id-type="doi">10.1021/ct200723y</pub-id><pub-id pub-id-type="pmid">22368531</pub-id>
</element-citation><mixed-citation id="mc-CR50" publication-type="journal">Hart K, Foloppe N, Baker CM, Denning EJ, Nilsson L, MacKerell AD (2012) Optimization of the CHARMM additive force field for DNA: improved treatment of the BI/BII conformational equilibrium. J Chem Theory Comput 8(1):348&#x02013;362. 10.1021/ct200723y<pub-id pub-id-type="pmid">22368531</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR51"><label>51.</label><citation-alternatives><element-citation id="ec-CR51" publication-type="journal"><person-group person-group-type="author"><name><surname>Pavelites</surname><given-names>JJ</given-names></name><name><surname>Gao</surname><given-names>J</given-names></name><name><surname>Bash</surname><given-names>PA</given-names></name></person-group><article-title>A molecular mechanics force field for NAD+, NADH, and the pyrophosphate groups of nucleotides</article-title><source>J Comput Chem</source><year>1996</year><volume>18</volume><issue>2</issue><fpage>221</fpage><lpage>239</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1096-987X(19970130)18:2&#x0003c;221::AID-JCC7&#x0003e;3.0.CO;2-X</pub-id></element-citation><mixed-citation id="mc-CR51" publication-type="journal">Pavelites JJ, Gao J, Bash PA (1996) A molecular mechanics force field for NAD+, NADH, and the pyrophosphate groups of nucleotides. J Comput Chem 18(2):221&#x02013;239</mixed-citation></citation-alternatives></ref><ref id="CR52"><label>52.</label><mixed-citation publication-type="other">MacKerell AD, Banavali NK (2000) All-atom empirical force field for nucleic acids: II. application to molecular dynamics simulations of DNA and RNA in solution. J Comput Chem 21(2):105&#x02013;120. 10.1002/(SICI)1096-987X(20000130)21:2&#x0003c;105::AID-JCC3&#x0003e;3.0.CO;2-P</mixed-citation></ref><ref id="CR53"><label>53.</label><citation-alternatives><element-citation id="ec-CR53" publication-type="journal"><person-group person-group-type="author"><name><surname>Denning</surname><given-names>EJ</given-names></name><name><surname>Priyakumar</surname><given-names>UD</given-names></name><name><surname>Nilsson</surname><given-names>L</given-names></name><name><surname>MacKerell</surname><given-names>AD</given-names></name></person-group><article-title>Impact of 20-hydroxyl sampling on the conformational properties of RNA: update of the CHARMM all-atom additive force field for RNA</article-title><source>J Comput Chem</source><year>2011</year><volume>32</volume><issue>9</issue><fpage>1929</fpage><lpage>1943</lpage><pub-id pub-id-type="doi">10.1002/jcc.21777</pub-id><pub-id pub-id-type="pmid">21469161</pub-id>
</element-citation><mixed-citation id="mc-CR53" publication-type="journal">Denning EJ, Priyakumar UD, Nilsson L, MacKerell AD (2011) Impact of 20-hydroxyl sampling on the conformational properties of RNA: update of the CHARMM all-atom additive force field for RNA. J Comput Chem 32(9):1929&#x02013;1943. 10.1002/jcc.21777<pub-id pub-id-type="pmid">21469161</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR54"><label>54.</label><citation-alternatives><element-citation id="ec-CR54" publication-type="journal"><person-group person-group-type="author"><name><surname>MacKerell</surname><given-names>AD</given-names></name><name><surname>Feig</surname><given-names>M</given-names></name><name><surname>Brooks</surname><given-names>CL</given-names></name></person-group><article-title>Improved treatment of the protein backbone in empirical force fields</article-title><source>J Am Chem Soc</source><year>2004</year><volume>126</volume><issue>3</issue><fpage>698</fpage><lpage>699</lpage><pub-id pub-id-type="doi">10.1021/ja036959e</pub-id><pub-id pub-id-type="pmid">14733527</pub-id>
</element-citation><mixed-citation id="mc-CR54" publication-type="journal">MacKerell AD, Feig M, Brooks CL (2004) Improved treatment of the protein backbone in empirical force fields. J Am Chem Soc 126(3):698&#x02013;699. 10.1021/ja036959e<pub-id pub-id-type="pmid">14733527</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR55"><label>55.</label><citation-alternatives><element-citation id="ec-CR55" publication-type="journal"><person-group person-group-type="author"><name><surname>Schuhmann</surname><given-names>F</given-names></name><name><surname>Kattnig</surname><given-names>DR</given-names></name><name><surname>Solov&#x02019;yov</surname><given-names>IA</given-names></name></person-group><article-title>Exploring post-activation conformational changes in pigeon cryptochrome 4</article-title><source>J Phys Chem B</source><year>2021</year><volume>125</volume><issue>34</issue><fpage>9652</fpage><lpage>9659</lpage><pub-id pub-id-type="doi">10.1021/acs.jpcb.1c02795</pub-id><pub-id pub-id-type="pmid">34327996</pub-id>
</element-citation><mixed-citation id="mc-CR55" publication-type="journal">Schuhmann F, Kattnig DR, Solov&#x02019;yov IA (2021) Exploring post-activation conformational changes in pigeon cryptochrome 4. J Phys Chem B 125(34):9652&#x02013;9659. 10.1021/acs.jpcb.1c02795<pub-id pub-id-type="pmid">34327996</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR56"><label>56.</label><citation-alternatives><element-citation id="ec-CR56" publication-type="journal"><person-group person-group-type="author"><name><surname>Schuhmann</surname><given-names>F</given-names></name><name><surname>Tan</surname><given-names>X</given-names></name><name><surname>Gerhards</surname><given-names>L</given-names></name><name><surname>Bordallo</surname><given-names>HN</given-names></name><name><surname>Solov&#x02019;yov</surname><given-names>IA</given-names></name></person-group><article-title>The same, but different, but still the same: structural and dynamical differences of neutrophil elastase and cathepsin G</article-title><source>Eur Phys J D</source><year>2022</year><volume>76</volume><issue>7</issue><fpage>1</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1140/epjd/s10053-022-00452-0</pub-id></element-citation><mixed-citation id="mc-CR56" publication-type="journal">Schuhmann F, Tan X, Gerhards L, Bordallo HN, Solov&#x02019;yov IA (2022) The same, but different, but still the same: structural and dynamical differences of neutrophil elastase and cathepsin G. Eur Phys J D 76(7):1&#x02013;14. 10.1140/epjd/s10053-022-00452-0</mixed-citation></citation-alternatives></ref><ref id="CR57"><label>57.</label><citation-alternatives><element-citation id="ec-CR57" publication-type="journal"><person-group person-group-type="author"><name><surname>Shahu</surname><given-names>MK</given-names></name><name><surname>Schuhmann</surname><given-names>F</given-names></name><name><surname>Scholten</surname><given-names>A</given-names></name><name><surname>Solov&#x02019;yov</surname><given-names>IA</given-names></name><name><surname>Koch</surname><given-names>KW</given-names></name></person-group><article-title>The transition of photoreceptor guanylate cyclase type 1 to the active state</article-title><source>Int J Mol Sci</source><year>2022</year><volume>23</volume><issue>7</issue><fpage>1</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.3390/ijms23074030</pub-id></element-citation><mixed-citation id="mc-CR57" publication-type="journal">Shahu MK, Schuhmann F, Scholten A, Solov&#x02019;yov IA, Koch KW (2022) The transition of photoreceptor guanylate cyclase type 1 to the active state. Int J Mol Sci 23(7):1&#x02013;17. 10.3390/ijms23074030</mixed-citation></citation-alternatives></ref><ref id="CR58"><label>58.</label><citation-alternatives><element-citation id="ec-CR58" publication-type="journal"><person-group person-group-type="author"><name><surname>Hani&#x00107;</surname><given-names>M</given-names></name><name><surname>Schuhmann</surname><given-names>F</given-names></name><name><surname>Frederiksen</surname><given-names>A</given-names></name><name><surname>Langebrake</surname><given-names>C</given-names></name><name><surname>Manthey</surname><given-names>G</given-names></name><name><surname>Liedvogel</surname><given-names>M</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Mouritsen</surname><given-names>H</given-names></name><name><surname>Solov&#x02019;yov</surname><given-names>IA</given-names></name></person-group><article-title>Computational reconstruction and analysis of structural models of avian cryptochrome 4</article-title><source>J Phys Chem B</source><year>2022</year><volume>126</volume><issue>25</issue><fpage>4623</fpage><lpage>4635</lpage><pub-id pub-id-type="doi">10.1021/acs.jpcb.2c00878</pub-id><pub-id pub-id-type="pmid">35704801</pub-id>
</element-citation><mixed-citation id="mc-CR58" publication-type="journal">Hani&#x00107; M, Schuhmann F, Frederiksen A, Langebrake C, Manthey G, Liedvogel M, Xu J, Mouritsen H, Solov&#x02019;yov IA (2022) Computational reconstruction and analysis of structural models of avian cryptochrome 4. J Phys Chem B 126(25):4623&#x02013;4635. 10.1021/acs.jpcb.2c00878<pub-id pub-id-type="pmid">35704801</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR59"><label>59.</label><citation-alternatives><element-citation id="ec-CR59" publication-type="journal"><person-group person-group-type="author"><name><surname>Hani&#x00107;</surname><given-names>M</given-names></name><name><surname>Antill</surname><given-names>LM</given-names></name><name><surname>Gehrckens</surname><given-names>AS</given-names></name><etal/></person-group><article-title>Dimerization of European Robin cryptochrome 4a</article-title><source>J Phys Chem B</source><year>2023</year><volume>127</volume><issue>28</issue><fpage>6251</fpage><lpage>6264</lpage><pub-id pub-id-type="doi">10.1021/acs.jpcb.3c01305</pub-id><pub-id pub-id-type="pmid">37428840</pub-id>
</element-citation><mixed-citation id="mc-CR59" publication-type="journal">Hani&#x00107; M, Antill LM, Gehrckens AS et al (2023) Dimerization of European Robin cryptochrome 4a. J Phys Chem B 127(28):6251&#x02013;6264. 10.1021/acs.jpcb.3c01305<pub-id pub-id-type="pmid">37428840</pub-id>
</mixed-citation></citation-alternatives></ref></ref-list></back></article>